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ABSTRACT 
 
Background and purpose. The purpose of the study was to determine the costs 
incurred on the average length of stay (ALOS) on patients with Human 
Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS) 
related illnesses admitted in hospital and whether there are any other significant costs 
involved. 
Method. A quantitative approach was used to collect data; analysed; interpretation and 
report writing. Purposive sampling and data collection was done using data collection 
sheet.  This was a retrospective cost analysis data from in-patients records (record 
review) of ages from 15 years to 49 years both gender. Data analysis and presentation 
of information was presented by the use of tables; different types of graphs and the 
interpretation thereof. 
Results. The study found that males (63%) with HIV Human Immunodeficiency Virus 
(HIV) and Acquired Immune Deficiency Syndrome (AIDS) related illnesses had longer 
average length of stay in a hospital compared to females. However, females illustrated 
higher in-patient costs but majority of patients had costs of between R0–R17 500. 
Patients with longer hospital stay (>3 days of hospitalisation) had higher in-patient 
costs. 
Conclusion. The findings also showed that in-patient care costs were directly 
proportional to length of stay with higher costs for HIV and AIDS patient management 
care. Our findings are consistent with other studies regarding higher economic 
implications of care for HIV infected persons being almost as twice as people who are 
HIV negative due to longer periods of hospitalisation.  
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CHAPTER 1 
 
ORIENTATION OF THE STUDY 
 
1.1 INTRODUCTION AND BACKGROUND 
 
Human Immuno-deficiency Virus (HIV) causing Acquired Immune Deficiency Syndrome 
(AIDS) is one of the major public health problems with adverse effects on the socio-
economic development of many countries, especially the least developing ones mainly 
found in the Sub-Sahara Africa (Mbuyazi, Mwisongo, Makundi, Pallangyo, Malebo & 
Mshana 2012:8). HIV and AIDS and its effect poses a very serious threat and continues 
to be a worry to human kind (Baratedi 2013:4). 
 
Worldwide, 35 million people were estimated to be living with Human Immunodeficiency 
Virus (HIV) in 2012. The Sub-Saharan region remains to be the epicenter of the HIV 
epidemic accounting for nearly 70% of the total burden. HIV/AIDS is now the leading 
cause of death in South Africa and the Northern Cape Province is among the one of the 
province with an increasing HIV prevalence (Statistics South Africa 2013:37).  An 
estimated 6.3 million people living with HIV were in South Africa, making the country the 
worst affected in the world. The prevalence rate of HIV in the Northern Cape was 17.5% 
according to antenatal survey which was conducted in 2013 in the Frances Baard 
District in South Africa. Frances Baard is the district where the study took place and it 
accounts for the highest HIV prevalence in the province with an estimated rate of 18.2% 
(NDOH 2013:64).  
  
The hospital on which the study was conducted is situated in one of the district in the 
Northern Cape Province and the district has a total population of 382 807. According to 
the Integrated Development Plan (IDP 2014:6), Frances Baard District is divided into 4 
sub-districts and has 2 district hospitals, 25 fixed clinics, 5 mobile clinics and 6 satellite 
clinics including 1 tertiary hospital which is where the study took place (IDP 2014:6). 
 
The hospital has a quadruple status; it provides primary health care (PHC) services for 
the surrounding areas as the clinics are operational forty (40) hours per week and no 
services after hours and weekends. There are no Level 1 and Level 2 hospitals and the 
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tertiary hospital has its own status of providing tertiary services. The hospital has 775 
active beds and Internal Medicine has 126 beds where the study was conducted. There 
are 33 different specialty disciplines which are all headed by qualified specialists. 
(NDOH 2013:64).  The description of level1 and level 2 are as follows: 
 
The District Hospital which falls under Level 1 provides the service package which 
includes trauma and emergency, in-patient care, out-patient visits, and paediatric and 
obstetric care. A limited number of level 2 services can be provided by larger district 
hospitals and these are provided by family physician, paediatrician, obstetrician/ 
gynaecologist and general surgeon. District hospitals are classified as small if they have 
less than 50 beds and not more than 150 beds, medium if they have 150 beds and not 
more than 300 beds and lastly large if they have 300 and not more than 600 beds. 
(NDOH 2013:64). 
 
The Regional Hospital falls under Level 2 and the service package at this level render 
services at a general specialist level and receive referrals from district hospitals. They 
also serve as a platform for training of health workers and research. These specialist 
disciplines are general surgery, orthopaedics, general medicine, paediatrics, obstetrics 
and gynaecologist, family medicine, radiology and anaesthetic (IDP 2014:8).  
 
The Internal Medicine Discipline has grown over the years due to the high demand of 
service delivery. A lot of successes and challenges had emerged especially with high 
demand of bed occupancy rate by HIV and AIDS related illnesses; this also has an 
impact on the morale of staff and very high turnover of professional nurses. There has 
been great improvement in the physical infrastructure of the wards; the department had 
procured high technology equipment. Health information systems (Nootroclin) was 
introduced at ward level and brought professional, effective and efficient ward 
management. There is also a multidisciplinary team which has been proven to be 
effective in managing patients holistically (IDP 2014:8).  
 
Therefore the information on costs of treatment and care of these patients is necessary 
in order to have knowledge of how much cost is spent.The cost analysis gives a 
detailed information as how much the current budget is used in providing the costs on 
length of stay and provides a baseline information for health planners for future planning 
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(Meyer-Rath, Brennan, Fox, Modisenyane, Tshabangu, Mohapi, Rosen & Martinson 
2013:323).   
 
UNAIDS, WHO and the United Nations Development Programme have documented a 
correlation between the decreasing life expectancies and the lowering of gross domestic 
product (GDP) in many African countries with prevalence rates of 10% or more. Indeed, 
since 1992 predictions that AIDS would slow economic growth in these countries have 
been published. The degree of impact depended on assumptions about the extent to 
which illness would be funded by savings and who would be infected (Over 1992:35).  
 
According to Over (1992:35), conclusions on the macroeconomic impact of AIDS on the 
Sub-Saharan economies of 30 countries  over the period 1990–2025 were that the 
economic growth rates of these countries would be between 0.56 and 1.47% lower due 
to AIDS epidemic . The impact on gross domestic product (GDP) per capita was less 
conclusive. However, in 2000, the rate of growth of Africa's per capita GDP was in fact 
reduced by 0.7% per year (Clements, Coady & Gupta 2012:43). 
 
The incidence rate of HIV in South Africa is 1.49 and is the lowest as compared to other 
neighbouring countries, which are Botswana, Swaziland and Lesotho (UNAIDS 2006). 
According to the annual antenatal survey conducted HIV prevalence amongst pregnant 
women attending public clinics excluding non-pregnant women showed that the HIV 
prevalence is at highest level at 29.5%. There are provinces which are affected most; 
the Kwa-Zulu Natal for example at 40.1% followed by Mpumalanga at 37.5%; Eastern 
Cape 31.4% Free State at 29.8% and the Northern Cape at 17.5% is amongst these 
provinces (NDOH 2013:23).  
 
The burden of HIV and AIDS cannot be under-estimated, with the recent HIV 
Counselling and Testing (HCT) campaign which was launched in 2010; more than 90% 
of people were tested and the target was 115 753 and 107 306 (93%) were counselled 
and tested; and 11 531 (11%) were tested positive (DHIS 2014). The activities which 
were carried out included drawing of blood for CD4 count, screening for Tuberculosis 
and putting those eligible on antiretroviral (ARV) treatment, thus adding to the number 
of patients who were already on highly active antiretroviral treatment (HAART) (DHIS 
2014).  
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The increased number of patients treated as outpatients and in-patients exert 
tremendous pressure and strain on health resources. The caring for HIV and AIDS 
related illnesses exert pressure on the limited resources (WHO 2012). HIV positive 
patients tend to be admitted more frequently to hospital due to their immunosuppressed 
state and this increases their risk of healthcare associated infections (HAI).The resulting 
HAI can lead to longer hospitalisation, economic burden and higher risk of mortality 
(Mitha, Furuya & Larson 2014:214)  
 
South Africa has a total population of approximately 54.96 million (0.7% of the world’s 
population). According to Statistic South Africa (2015:1), 6.19 million people are living 
with HIV (17% of global burden); 2.7 million of them are receiving antiretroviral 
treatment and these efforts have been largely financed from its own domestic 
resources. HIV prevalence for adult population (15−29 years) is estimated at 16.6%, 
and the overall population prevalence rate is 11.2%. The disease has impacted 
significantly on life expectancy which is currently 54.9 years for men and 59.9 years for 
women (Statistics South Africa 2015:1).  
 
According to the National Department of Health (2015) there are 1 000 new infections 
and more than 1 000 AIDS-related deaths daily. According to the HSRC’s National HIV 
Prevalence, Incidence and Behaviour Survey that was released in April 2015, the total 
number of infected South Africans were 1.2 million more than in 2008. Girls and women 
were the most affected by HIV and followed by the newly identified as key populations 
with higher risk of exposure: black African females between the ages of 20 and 24 years 
(at a rate of 31.6%), people who are co-habiting (30.9%), black African males between 
ages of 25 and 49 years (25.7%) disabled persons over the ages of 15 years (16.7%), 
high-risk alcohol drinkers over the age of 15 years (14.3%) and reactional drug users 
(12.7%) (HSRC 2015).  
 
Over 280 000 people died of AIDS-related illnesses (HSRC 2015). The HIV and AIDS 
epidemic in South Africa also affects children in many ways. Estimates suggested that 
there are approximately 300 000 HIV-infected children and with 50 000 new infections 
occurring each year. HIV prevalence indicates the proportion of young people infected 
with HIV increasing significantly between childhood (2−14 years) and youth (15–24 
years) suggesting that as children progress from childhood to youth their vulnerability to 
HIV infection increases substantially (Abdool-Karim et al 2014:29).  
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In 2012 an estimated 410 000 children aged 0 to 14 years were living with HIV. The 
study showed that there was a decline from 2002 to 2012 due to programmes which 
were put in place amongst others prevention of mother-to-child-transmission (PMTCT) 
and scaling up of retroviral treatment. There are also 2.5 million children who have been 
orphaned by HIV/AIDS. These orphans are vulnerable to HIV transmission as they are 
forced into sex in exchange for support and typically become sexually active earlier than 
other children (DOH 2014).  
 
In many settings in AIDS stricken countries working conditions for health workers 
became so difficult, salaries very low and inadequate resources (equipment and 
shortage of staff). All these unfavourable conditions resulted in poor quality care though 
not evident and responsiveness of staff towards AIDS patients may suffer (Unger, Welz 
& Haran 2003; Shisana, Hall, Maluleke, Stoker, Schwaib, Schwabe, Colvin, Chauveau, 
Botha, Gumede, Fomundam, Shaikh, Rehle & Udjo 2003).  
 
Despite the good political leadership under the auspice of Dr Motsoaledi, South Africa is 
still experiencing some challenges such as lack of knowledge and education especially 
in rural areas; low rate of condom use and sufficient distribution and early sexual 
debates and HIV-related risk behaviours.  
 
The HIV/AIDS related burden of disease increases demand for medical care and in so 
doing it indirectly affects the health workforce in terms of emotional, physical and mental 
stress. Tuberculosis (TB) pneumonia and other opportunistic infections and malnutrition 
were all on the rise in the AIDS-stricken countries. Public hospitals carry the heaviest 
burden as witnessed by data on the HIV-related admissions and the length of stay. The 
HIV/AIDS-related admissions in all categories of hospitals increased by a factor of 7 
(Shisan et al 2003). As a result 46% of patients admitted to hospitals were HIV positive 
and AIDS patients shown to stay longer (mean length of 13.7 days) than non-AIDS 
patients (mean length of stay 8.2 days) for all categories of hospitals combined (DHIS 
2014).  
 
According to Statistics South Africa (2013:37), HIV/AIDS is the leading cause of death 
in the province. Evidently the increased burden on hospital exerts an impact on morale 
and job satisfaction of health workers. HIV/AIDS patients are often brought to the 
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hospital at an advanced stage of illness, resulting to high inpatients deaths rates 
combined with limited possibilities of effective care contributed to professional 
frustrations, higher absenteeism; burn-out and low staff morale. The study analysed 
how HIV and AIDS related inpatient admissions have direct impact on the length of stay 
(LOS) from a cost perspective for patients in a public hospital in the Northern Cape.   
 
1.2 RESEARCH PROBLEM 
 
The impact of HIV and AIDS on health care sector is exacerbated by the factors which 
are secondary to HIV infections and these are the opportunistic infections (pneumonias 
and tuberculosis) and other HIV-related diseases. These are all adding pressure on 
health services which are already diminished and increasing demand on the limited 
resources. Information on costs of treatment and care of HIV and AIDS patients in 
health facility was necessary in order to give an idea of increasing number of AIDS- 
related admissions (Bachmann & Booysen 2003:3).  
 
With the number of patients admitted per month thus cost the hospital exorbitant 
amounts of money for example number of patients multiply by number of days spent in 
hospital multiply by cost per patient admission (44*6* R3 500=R924 000), this was the 
total expenditure per month (DHIS 2014). This information on costs of admission of 
these patients in this health facility was necessary in order to guide the budget 
allocation and designed alternative cost effective programs and services for HIV and 
AIDS patients to curb admission to the wards. The burden of care and support has 
fallen heavily on the shoulders of impoverished rural communities, where sick family 
members return home when they could no longer work or care for themselves; 
community-based care has been promoted as the best option since it would be possible 
to care properly for hundreds of people dying from AIDS in public hospitals (Catumbela, 
Freitas, Lopes, Mendoza, Costa, Sarmento & Da Costa-Pereira 2015:7). 
 
Health system in both public and private has become dominated by the needs of AIDS 
patients and there has been a consequent squeeze on resources for treating other 
illnesses. Socially the impact is devastating given the human cost of much illness and 
many deaths, while the rise in the number of orphans and breakdown of family 
structures poses challenges for both state and social support system. There were 
probabilities of increased poverty as households face reduction in income (as 
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breadwinners became sick and die) and increased in expenditure on medical related 
costs (Hansen, Chapman, Chitsike & Mwaluko 2000:2).  
 
HIV/AIDS affects the size of the labour force, the availability of skills and productivity. It 
also affects the labour force and caused resources to be diverted. HIV/AIDS had impact 
on macroeconomic growth per capita incomes, savings, investment and employment. 
For government department HIV/AIDS had an adverse fiscal impact, as expenditure 
rose with higher spending on health care and social support, and revenues were 
affected by slower growth cited by (Hansen et al 2000:2).  
 
1.3 AIM OF THE STUDY 
 
The aim of this study was to determine the costs paid per patient admission and also 
established financial implications on the length of stay on patients with HIV/AIDS related 
illnesses who were admitted in the medical ward.  The study will provide cost 
information for planning; give guidance on the budget allocation; design alternative cost-
effective programs and services for patients with HIV and AIDS related illnesses instead 
of admitting them.  
 
1.3.1 Research objectives 
 
The study was guided by the following objectives: 
 
• To determine the costs of length of stay in caring for HIV positive and AIDS 
patients admitted in hospital. 
• To identify cost containment strategies in caring for HIV positive and AIDS 
patients.  
 
1.4 RESEARCH HYPOTHESIS 
 
Hypothesis is a statement of the researcher’s expectations about the relationship 
between variables in other words is the predictions of expected outcomes. Most 
quantitative studies are designed to test hypothesis through statistical numerical 
analysis (Polit & Beck 2008:66). There are two forms of hypotheses (a) null and (b) 
alternative. A null hypotheses state that there is no relationship between the variables; 
  
8 
for example on the study the null hypothesis (H0) is that there is no significance that HIV 
and AIDS patient admission has cost implications on the length of stay. Statistical 
hypothesis testing is basically a process of rejection and it cannot be demonstrated 
directly that the research hypothesis is correct, but using theoretical sampling 
distribution, it can be shown that the null hypothesis has a high probability of being 
incorrect (Polit & Beck 2008:587-588). 
 
 Alternative hypothesis (HA) claims that the means are not the same and it is what you 
might believe to be true or hope to prove for example HIV/AIDS related illnesses exhibit 
significant cost implication on length of stay (LOS) (Polit & Beck 2008:588).   
 
The hypothesis in the study is: Is length of stay a significant cost factor on patient 
admission in a public hospital?  
 
1.5 SIGNIFICANCE OF THE STUDY 
 
What is the envisioned significance of this study? 
 
The baseline data will assist health planners to plan for future needs in terms of budget 
allocation for HIV management. The study will inform the hospital and the provincial 
department of health financial burden as the result of HIV and AIDS related illnesses.  
 
The study findings will assist to address the economic issues exacerbated by HIV and 
AIDS. These include, public financing of health care services and assist the policy 
makers to make decisions about proper provision and financing for HIV related care 
costs. 
 
1.6 DEFINITIONS OF KEY CONCEPTS  
 
Acquired Immune Deficiency Syndrome (AIDS) is a cluster of diseases associated 
with loss of cellular immunity in adults who had no obvious reason for presenting such 
immune deficiencies (NDOH 2010:88).   
 
Human Immuno-deficiency Virus (HIV) is the virus that attacks the body’s CD4 cell (T 
cell) that leads to destruction of human immune system (NDOH 2010:88). 
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Economic impact of the disease (HIV and AIDS) is the macroeconomic effect on 
commerce, employment or incomes produced by a decision, event or policy. The total 
costs and benefits that a situation (length of stay) can have on the overall economy and 
in this case the budget of the institution. HIV has reduced the economic growth rate by 
0.3%–4% per annum and it has also reduced the life expectancy and reverses the 
progress in economic development particularly through the decline of life expectancy. 
The macro-economic impact has a variety of factors that interplay; the direct and 
indirect costs related to HIV/AIDS might cause the shift from savings to current 
productive to the unproductive spending as a result this limit the fixed economic growths 
(Business dictionary.com). 
 
Cost analysis: This is the breaking down of costs to the identification of current and 
anticipated costs associated with providing a service with an examination of the impact 
of those costs on the length of stay with the anticipation of break-even for the purpose 
of disclosing and reporting on condition subject to improvement (Huber 2006:758).  
 
Cost-effectiveness analysis compares decision options in terms of monetary; for the 
study the cost analysis of HIV and AIDS related hospitalisation calculating the cost per 
patient admission (PDE). Cost-effectiveness analysis involves identification of costs for 
decision options and evaluation of these costs and in many cases determines health 
outcome decision options. Once the problem has been identified and the theoretical 
framework has been determined data on costs and outcomes are gathered therefore 
cost per patient admission is determined (Huber 2006:111). 
 
Patient day equivalent (PDE) average cost per patient admission (inpatient days) and 
it monitors the effective and efficient management of inpatient facilities. This is a 
measure of the volume of patients seen in hospital also account for all the patients that 
do not spend a full day (from midnight to midnight) at the hospital as these day patients, 
out-patients and emergency room visits patients add to the workload of the hospital 
calculated in the equivalent number of 24-hours in-patients (WHO 2012). 
 
  
  
10 
1.7 OPERATIONAL DEFINITIONS 
 
Average length of stay (ALOS): The average length of stay in hospital is a statistical 
calculation often used for planning purposes and measures the main outcome of the 
patient stay. It is calculated by dividing the number of inpatient days by the number of 
separations and expressed as number of days. The ALOS is a proxy measure for the 
quality of care received as well as of the efficiency of the hospital (NIDS 2015). 
 
Total discharge days: This is the sum of the number of days spent in hospital for each 
inpatient who was discharged during the time period examined regardless of when the 
patient was discharged. The number of inpatients released (separations – transfers; 
discharges and deaths) from the hospital during the time period examined (NIDS 2015). 
 
Total inpatient days of care: It is a sum of each daily inpatient census for the time 
period examined. For instance, if the period examined was a week the calculation is 
based only to 7days. As opposed to discharge days which count all days the patient 
was in the facility regardless of date of admission; inpatient days of care are days of 
service for those patients admitted during a specific time period (NIDS 2015). 
 
1.8 THEORETICAL FOUNDATION OF THE STUDY 
 
Theory is defined as interrelated set of constructs or variables formed into proposition or 
hypothesis that specify relationships among variables.  Theory explains the phenomenal 
‘hypothesis of the study. Theories in research are in a form of interconnected 
hypotheses and are influences by the series of processes. Once the problem has been 
identified and the theoretical framework has been determined data on costs and 
outcomes are gathered therefore cost per patient admission is determined (Creswell 
2014:52). Each branch of scientific enquiry is based on asset of theoretical perspectives 
or paradigms which consist of a set of assumptions on which the research questions are 
based (Bowling 2009:129). 
 
1.8.1 Research paradigm  
 
A paradigm is the way of looking at natural phenomenon that encompasses a set of 
philosophical assumptions that guides approach enquiry (Polit & Beck 2008:761). The 
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study will be guided by positivism which is a reflection of a broader cultural 
phenomenon that in humanities is referred to as modernism which emphasizes the 
rational and scientific nature. The approach assumes that the nature is basically 
ordered and that an objective reality exists and the epistemology is independent of 
human observation and the findings are not influenced by the researcher. Emphasis is 
on discrete specific concepts and the focus is quantifiable (Polit & Beck 2008:14-15). 
 
1.9 RESEARCH METHOD  
 
Quantitative research method, using exploratory descriptive statistics guided data 
collection for the study. The research project adhered to the retrospective study design 
in collecting information from the patient’s records which met the inclusion criteria. The 
quantitative approach is a formal, objective, systematic process for obtaining 
quantifiable information and this data is presented in a numerical form analysed through 
the use of statistics. This method is used to describe variables and test relationship and 
also examine the cause-and-effect between variables (Burns & Grove 2005:23). 
Retrospective designs are popularly used in social sciences to investigate the social 
phenomena and are relevant in providing useful indications for future investigation 
(Bowling 2009:217).  
 
1.10 ETHICAL CONSIDERATION 
 
Confidentiality and anonymity were the only relevant ethical principles that guided the 
study. The study was not directly involved with the subjects but confidentiality, 
anonymity and respect were maintained as only patient’s records were used. The 
researcher was only dealing with retrospective record review. For the purpose of 
confidentiality no names were disclosed and records obtained were kept under strictest 
confidence in a lockable cabinet. The findings from the records could not be traced to 
any person.  Only the researcher and Senior Records Clerk had access to the files.  
 
The Ethics Clearance was approved by Ethics Committee at University of South Africa 
(UNISA) (see annexure A). A letter and research proposal was submitted to the 
Provincial Review Committee (see annexure B), letter of approval from Provincial 
Health Research and Ethics Committee (see annexure C), letter to the Chief Executive 
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Officer and approval (see annexure D), letter to the Medical Director who is responsible 
for medical records and approval (see annexure E).   
 
1.11 STRUCTURE OF DISSERTATION 
 
Chapter 1: Overview of the whole study 
Chapter 2:  Literature review 
Chapter 3:  Methodology 
Chapter 4:  Presentation of findings 
Chapter 5:  Conclusion; limitations and recommendations 
 
1.12 CONCLUSION 
 
The purpose of this chapter was to provide an overview of the study that was 
conducted. The rationale, problem statement and objectives were clearly outlined.  
 
The research design and methods used were identified and concluded with explanation 
of ethical principles that were adhered to throughout the study. 
 
In chapter 2 the detailed literature review is presented. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
The purpose of this chapter is to present the literature relevant to the topic of study. 
Polit and Beck (2008:757) define a literature review as the critical summary of the topic 
of interest prepared to put the research problem in context. The purpose of literature 
review is to present a strong knowledge base of what is already known about the 
research topic or project. This will provide a foundation on which to base new evidence 
(Polit & Beck 2012:58).  
 
This chapter will bring extensive literature that was reviewed based on the title of the 
study. Databases that were consulted are PubMed, Academic Search Premier; EBSCO 
host; SABINET and other approved research dissertation and repositories.  
 
The following key words were used to conduct literature search: 
 
• Length of stay 
• Cost analysis 
• Economic impact 
• Patient admissions 
 
2.2 LENGTH OF STAY 
 
The length of stay determines the number of days spent by a patient in a hospital for 
more than twenty four hours and is an indicator of the cost incurred by that particular 
patient. There are very few studies which were done in South Africa on the length of 
stay for patients admitted with HIV diseases such as Shisana et al (2003), Xaba, Greef 
and Becker (2014:189), Bachmann and Booysen 2006:14; Booysen and Van der Berg 
(2006:563) and Schoeman (2009:46). 
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The study done by Catumbela et al (2015:2) in Portugal examined the trends of 
HIV/AIDS- related in-patient admission, cost and length of stay (LOS).The findings 
demonstrated that the median (LOS) was 11 days and it was significantly higher in men 
than woman.  
 
According to the study done by Mubyazi, Mwisongo, Makundi, Pallangyo, Malebo, 
Mshana et al (2012:8), they examined how the health services related to HIV/AIDS can 
also impose regressive cost burden with poor household spending. The findings 
estimated that length of stay by HIV/AIDS positive patients were longer than five (5) 
days compared to HIV negative patients. The impact of HIV/AIDS related burden of 
disease increased the demand for medical care. Public hospitals carry the burden as 
witnessed by data on HIV/AIDS related admissions, 72% of deaths were recorded at the 
study hospital. Cost analysis was difficult to determine the actual costs due to the 
missing data (Mubyazi et al 2012:8).   
 
Gaugham, Mason, Street and Ward (2012:21) investigated variation in costs and length 
of stay (LOS) among ten clinical treatments. Their findings discovered that the length of 
stay was significantly longer for patients who were cared for by more than one doctor 
regardless of treatment received. Other findings suggested that all hospitals have scope 
to make efficiency in a small number of hospitals that have higher average costs or 
(LOS) across multiple treatments than their counterparts and this could not be explained 
by character of their patients or quality. 
 
According to the study done by Thungjaroenkul, Cummings and Embleton (2007:255-
256) which was to determine a systematic review of the effects of nurse staffing on 
patient outcomes including the length of stay (LOS) and costs, few studies reported that 
there was a relationship between nurse staffing, length of stay and costs. Their findings 
revealed that there is a relationship between sufficient staffing, quality patient care, the 
reduction on length of stay and decreased care cost (Thungjaroenkul et al 2007:255-
256). 
 
Schoeman (2009:46-52) did a study on the clinical spectrum and cost implications of 
hospitalised HIV-infected children; the aim was to describe the demographic patterns as 
well as cost implication and the length of stay. Findings suggested that the costs of 
hospitalising HIV-positive children is significantly more than HIV-negative controls, 
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which increased the financial burden on the already restricted health resources as the 
HIV positive children stay longer in hospital.  
 
Xaba, Greef and Becker (2014:189) conducted a study on the determinants, outcomes 
of antibiotics in the treatment of community acquired pneumonia (CAP). HIV infection is 
a major risk factor for pneumonia that is why people with HIV disease were included in 
the study. The findings reported that HIV positive patients led to a slightly longer 
hospital stay after treatment with ceftriaxone vs amoxicillin-clavulanate, however, this 
was not statistically significant.    
 
Okunji and Daniel (2015:110-118) examined the synergy between substance, alcohol 
abuse, HIV transmission and also the training of nurses in these institutions. People 
with mental and behavioural disorders were likely to be at high risk of HIV transmission. 
The study revealed that the effects of patients and hospital characteristics as it related 
to inpatients hospitalised with HIV/AIDS in 2007–2010. Most importantly was the 
difference observed in the ranking of length of stay (LOS) for the HIV/AIDS inpatients 
and increased number of nurses trained especially for the Bachelor’s Degree (Okunji & 
Daniel 2015:110-118). 
 
Lim and Tongkumchum (2009:25) conducted a study to investigate the length of stay 
(LOS) for patients who died in hospital in Southern Thailand from 2000 to 2003 with 
respect to principal diagnosis and demographic, geographic and hospital size factors. 
The results showed that patients with primary injuries had shortest LOS, whereas 
cancer patients had the longest LOS. Patients particularly females had the longest of all 
types of diagnosis (Lim & Tongkumchum 2009:25).  
 
Van den Block, Deschepper, Drieskens, Bauwens, Bilsen, Bossuyt and Deliens 
(2007:69) conducted the study to describe hospital use in the last three months of life in 
Belgium and identify associated patient, disease and healthcare factors. The findings 
reported the increased percentage of patients hospitalised during the last week before 
they die (Van den Block et al 2007:69). The increased number of patients who were 
admitted  in hospitals had a negative  economic impact in the country.  
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2.3 ECONOMIC IMPACT 
 
Booysen and Van der Berg (2005:109) examined health and economic impact of AIDS 
related illness on South African household. The impact of AIDS related illness on 
household income could be varied depending on the stage of illness and the identity of 
the person who is doing the caring. They also find out that the social grants mitigate the 
impact of AIDS illness and deaths; however such grants did not totally insulate 
household from income shocks (Booysen & Van der Berg 2005:109).  
 
Bachmann and Booysen (2006:1861-1867) noted that the macro-economic impact of 
AIDS in South Africa had obvious negative economic consequences; household suffer 
from death of income earners and the erosion of savings and investment as resources 
are channeled into health care cost. This also have the worst impact on health care 
system as the public health care facilities should carry the burden of the disease 
(Bachmann & Booysen 2006:1861-1867). 
 
According to Whiteside and Henry (2011:23), on a study that was conducted on the 
socio-economic impact of HIV/AIDS in Swaziland confirmed that HIV/AIDS affects 
economic growth by reducing the size of the labour force, by lowering efficiency, 
productivity, savings and investments. Furthermore, in the study conducted by 
Whiteside, Russell and Seeley (2010:24) which examined how HIV/AIDS can affect the 
economic growth on the physical, human capital accumulation and total factor 
productivity. Findings were that household level prolonged morbidity and mortality due 
to HIV/AIDS increased expenditure as a result of health care and funeral cost, reduced 
savings and income due to loss of remittances, loss of labour force and institutional 
memory. All these had direct and indirect economic impact on the labour force 
(Whiteside & Henry 2011:23).  
 
The study done by Jefferis, Siphambe and Kinghorn (2006:207) showed how HIV/AIDS 
has an impact on government employees. The most visible impact was on increased 
morbidity and mortality, increased absenteeism, sick leaves, attrition and the new 
recruits affect productivity in the work place which also added to the economic impact 
and fiscal cost (Jefferis et al 2006:23).  
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According to Matshe and Pimhidzai (2008:33), the study they conducted was to 
examine the macro-economic impact of HIV and AIDS on the Zimbabwean economy on 
human capital approach. Findings were that HIV/AIDS had wide implication for 
Zimbabwean economy as it affected the economy’s capacity to accumulate human 
capital stock, diminished labour supply as well as labour productivity. Using human 
capital approach, the results showed that HIV/AIDS led to a 13.32% of 1993’s Gross 
Domestic Product (GDP). The increased morbidity and mortality have direct implications 
on the macroeconomic performance of Zimbabwean economy (Matshe & Pimhidzai 
2008:33). 
 
The multi-country study done by Carael, Marais, Polsky and Mendoza (2009:249) noted 
that the hospital services in Nairobi, Kenya had tremendous economic impact on 
hospitalisation due to increased admissions and premature deaths of employees due to 
HIV/AIDS related illnesses and loss of skills. In Cote D’ Ivoire and Uganda 50% to 80% 
of hospital beds occupied were occupied by patients admitted with HIV/AIDS related 
illnesses. In Swaziland the average length of stay increased from 6.0 days to 30.4 day 
for patients who were co-infected having tuberculosis (TB) and HIV/AIDS (Carael et al 
2009:249). 
 
According to the study done by Shisana et al (2003) who examined the impact of 
HIV/AIDS on the health sector, the findings demonstrated that HIV/AIDS reduced the 
economic growth rate by 0.3–4% per annum. It has also reduced the life expectancy 
which reversed the progress in the economic development particularly through the 
decline of life expectancy. However in general it was difficult to assess the macro-
economic impact of variety factors which are at interplay (Shisana et al 2003:25). 
 
The study done by Langeni (2012:21) in Kwa-Dlangezwa was to investigate the 
economic impact of HIV/AIDS on the rural households. The study also investigated the 
hypothesis that AIDS had massive economic impact on families infected and affected by 
HIV/AIDS. At household level AIDS resulted in loss of income, assets, and savings; and 
also increased in spending health care cost. Other results revealed that seventy one 
(71%) of respondents believed that AIDS had a negative impact on the level of income 
and fifty seven (57%) believed that AIDS had a negative impact on assets and 
household (Langeni 2012:23).   
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The study conducted in Uganda examined the economic impact of HIV/AIDS (Jefferis et 
al 2006). Findings showed that there was a smaller increase in poverty rate by 6% from 
37.7% to 43.7%. The long-term impact on households was loss of income by a 
breadwinner and impact on funeral cost; and another study which was done in Uganda 
by UNDP (2008) was to assess the macro-economic impact of HIV/AIDS (2008).  The 
findings stated that HIV-1 infection has changed focus as a rapid lethal disease to a 
chronic manageable condition, compatible with very long survival. This had special 
implications on public health around the work as the work affect the cycle of economy 
and civil stability (UNDP 2008).  
 
According to Mubyazi et al (2012:11) in study done in Tanzania on the analysis of cost 
impact of HIV/AIDS on the health services provision noted that HIV/AIDS caused 72% 
of all deaths that were recorded in hospital. The cost impact of HIV/AIDS to the health 
section has high demand on the minimal resources which were available (Mubyazi et al 
2012:11). 
 
According to the study done by Gow, George, Quinlan and Thurlow (2007:27) the aim of 
the study was to estimate the economic impact of HIV infection on the KwaZulu-Natal 
(KN) provincial economy. The economic assessment was not limited to household but 
also to other factors and institutions in an economy such as firms, markets and 
government. The findings reported a decline in the labour supply which was larger than 
in the population growth. Population growth fell by 1.06% whereas employment growth 
rate fell by 1.12% (Gow et al 2007:27). 
 
Murzalieva, Aleshkina, Temirov, Samiev, Kartanbaevaeva, Jakab et al (2009:10) did a 
study with the purpose of determining the experiences of people from the Kyrgyz 
Republic on how global HIV/AIDS initiatives impact on the health care system. The main 
purpose of the research was to track the effects of the major global HIV initiatives. They 
reported that there was lack of knowledge and public awareness on transmission of HIV 
infections. They recommended strategies to intensify and improve knowledge 
(Murzalieva et al 2009:10).  
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The recommendations are as follows: 
 
• Government to explore ways of increasing the amount of public spending on 
HIV/AIDS services. 
• Improving coordination and cooperation among financing organisations. 
• Unify current approaches to monitoring and evaluation from HIV/AIDS related 
activities (Murzalieva et al 2009:35). These recommendations are also relevant 
to the South African context in maximising the efforts on HIV/AIDS management. 
 
Semigina, Griga, Bogdan, Pavlenko, Bandar, Nechiporencho, Schevchenko and Spicer 
(2008:8) conducted the study to explore the effects of global HIV/AIDS initiatives on the 
Ukrainian health system. The study focused largely on global funds to fight AIDS, TB 
and Malaria (Global Fund) which is the largest external funder of HIV/AIDS 
programmes. Recommendations were to review the system of distributing funds among 
sub-recipients; increased transparency and improved access to HIV/AIDS services 
(Semigina et al 2008:8). 
 
According to Veenstra and Whiteside (2005:197), their study was to determine what 
would be the economic effects on the general population and the economic impact of 
HIV/AIDS. Their predictions were that costs associated on human capital were high due 
to HIV/AIDS epidemic. Prevention and treatment were the strategies they thought would 
save the government. Their findings revealed that health services were suffering under 
a dual burden of increased demand and reduced capacity to deliver which contributed 
to a cycle of poor health and economic decline (Veenstra & Whiteside 2005:197).  
 
Tawfik and Kinoti (2003:21) examined the impact of HIV/AIDS on health system and the 
workforce in Sub-Saharan Africa. Their findings noted that there was an increased 
demand for health services as a result of  the epidemic and the decrease in productivity 
were also due to ill-health and death of service providers (Tawfik & Kinoti 2003:21). 
 
Russel (2004:1) did a study to measure the economic costs and consequences of 
illness for households focusing on malaria, tuberculosis (TB), and HIV/AIDS. He also 
examined the direct and indirect cost on the households due to illness and highlighted 
the need to increase health interventions. The findings were the direct cost burden of 
illness was catastrophic for households greater than 10%. The catastrophe that 
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accompanied HIV/AIDS meant that many households in the developing countries were 
struggling rather than to cope, and the viability was often threatened causing them to be 
impoverished through loss of income (Russel 2004:1). 
 
2.4 COST ANALYSIS 
 
Catumbela et al (2015:2-10) conducted a study on HIV disease burden, cost, length of 
stay in Portuguese hospitals from 2000 to 2010.  The study was conducted to determine 
the costs, length of stay and impact of HIV-related admissions per year over a period of 
ten years and the results showed that there were variations over the years where there 
were reductions on the length of stay from 12 days to 10 days and thus resultant to 
reduction on costs (Catumbela et al 2015:2-10).  
 
Hansen et al (2000:434) conducted a study on the cost of HIV/AIDS care at government 
hospitals in Zimbabwe and the findings showed that estimated costs per in-patient day 
as well as per in-patient stay in the government facilities were high. The costs per in-
patient day and per patient day were estimated through a combination of two methods 
namely; bottom up costing methodology and through in-patient note review. The impact 
of HIV/AIDS-related burden of diseases increases the demand for medical care. Public 
hospitals carry the heaviest burden as witnessed by data on HIV-related admissions 
(Hansen et al 2000:434).  
 
Nosyk, Sun and Annis (2014:546) did a study on the effects of homelessness on 
hospitalisation among patients with HIV/AIDS and the purpose of the study was to 
determine the effects of homelessness on the costs and patterns of hospitalisation in 
patients with HIV/AIDS. The results suggested that homeless people had a large 
proportion of total costs attributable to admissions for acute events related to 
progression of diseases (Nosyk et al 2014:546).  
 
Drummond, Sculpher, Torrance, Brien and Stoddart (2005:3) wrote a book and their 
purpose was to develop the means of measurement and evaluation of health 
interventions and tools for patient data analysis in a decision-analytic modelling.  
Different methods were designed for example cost-utility which is the form of economic 
evaluation of the consequences of programmes adjusted by the state. This approach is 
useful for those health treatments or programmes that extend life only at the expense of 
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side-effects (Drummond et al 2005:3).HIV patients are exposed to different health 
treatments and programmes which are aimed at prolonging their life span  
 
Guthrie (2003:29) conducted the study that focused on budget allocation and the 
analysis of actual expenditure against allocated amounts for HIV/AIDS. The findings 
revealed that South Africa had detailed quarterly reports on expenditure which were 
published by the national treasury. There were cases where actual disbursements were 
being lower than the amounts of the originally allocated in budgets (Guthrie 2003:29). 
 
Hutton, Wyss and Diekhor (2003:117) conducted the study to identify the most cost-
effective options for HIV control. This study was done in Chad as well as in most sub-
Saharan African countries. The findings demonstrated that HIV poses a massive public 
health threat as well as economic burden with prevalence rates estimated at 9%. 
Recommendations were peer education and screening of blood donors. In order for the 
countries to reduce HIV, the prevention and control strategies should be introduced 
gradually and in phases (Hutton et al 2003:117). 
 
In a paper by Seshamani and Gray (2004:556) to obtain well-founded estimates of the 
effects of demographic change on future health expenditures, the findings revealed that 
the expenditure projections had to examine the effects of age on health care costs but 
this study failed to account the influence of future life expectancy. There was a decline 
in age-specific mortality rates over time which postpone death to later ages, pushing 
back death-related costs. The study also strongly confirmed that the pressure of 
population increases and aging of demographic structure on hospital expenditures 
would particularly countered by postponement of death-related hospital costs to later in 
life (Seshamani & Gray 2004:556).   
 
Thomas, Manning, Holmes, Naidoo, Van Der Linde, Gray and Martinson (2007:410) 
conducted a comparative study in one of the hospitals to determine the cost incurred in 
carrying for HIV infected versus un-infected adults and children. The findings were that 
the length of stay (LOS) and intravenous fluid utilisation of HIV-infected adults and 
children were greater than those who were not infected (Thomas et al 2007:410). 
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2.5 PATIENT ADMISSIONS 
 
Hajiabdolbaghi, Jafari, Mansouri and Yaghoobi (2014:546) conducted a study to 
determine the causes of hospitalisation and its related factors in HIV/AIDS patients. 
Patients with opportunistic infections had significantly lower CD4 counts and longer 
hospitalisation than other diseases. Their findings reported  that the most hospitalised 
HIV/AIDS patients in the study period were men with a history of intravenous drug users 
(IDU) and CD4 count less than 200 .These were patients who were at an advanced 
stage of AIDS and most prevalent cause of admissions were opportunistic infections of 
pulmonary tuberculosis (TB) (Hajiabdolbaghi et al 2014:546). 
 
Govender, Mabuza and Ogunbanjo (2015:1) conducted a study on the characteristics of 
HIV and AIDS patients with deep vein thrombosis. The aim was to present a profile of 
HIV and AIDS patients who developed deep vein thrombosis (DVT) in their primary care 
in a ward. Their findings reported that patients who are HIV positive are likely to develop 
DVT due to their susceptibility to a hyper-coagulation state including lower protein S-
Levels. The mean duration of stay was 14.1 days versus 4.0 days in those who were 
HIV negative (Govender et al 2015:1). 
 
2.6 DIRECT AND INDIRECT FACTORS 
 
There are various factors associated with HIV/AIDS, impact on household, decline in 
labour supply and total population due to HIV/AIDS related mortality which affects the 
economically active population. HIV/AIDS is believed to be responsible for slowing the 
economic growth of the gross domestic product (GDP) by more than 1% and large 
portions of budget and expenditure are directed at health care programmes (Whitefield 
et al 2010:44).  
 
Legislation as well as rules and regulations are depending on the availability of political 
will and strong management system for the implementation. New demographics and 
health needs require changes in the delivery of health care; these have impact on the 
delivery of health. Direct and indirect costs and losses to the both private and public 
sector due to HIV/AIDS included experiencing higher expenditure due to health care 
costs and payment of other employee benefits as well as absenteeism and high staff-
turnover. Other factors were loss of skills due to ill-health or death resulting to low 
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morale to the remaining workers which resulted in increased household’s expenditure 
(Booysen, Le, Geldenhuys & Marinkov 2003:6).  
 
2.7 CONCLUSION 
 
The chapter discussed the literature review conducted for the study. Various articles 
were reviewed covering length of stay (LOS), the economic impact of HIV/AIDS and 
cost analysis. Most of the articles which were reviewed showed that there was a link 
between all three variables of the study. In chapter 3 the research design and 
methodology will be discussed in detail. 
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CHAPTER 3 
 
METHODOLOGY 
 
3.1 INTRODUCTION 
 
Research methodology is a detailed discussion of the actual application of the design. It 
describes the methods, techniques and procedure that are used in the process of 
implementing the research design (Streubert-Speziale & Carpenter 2011:366). 
Research design and methodology of this study included population, sampling and 
sample, data collection and analysis; data collection instrument and ethical 
considerations. Patient’s folder numbers were obtained from admission books in the 
three wards and an audit conducted in order to determine the length of stay. The study 
reviewed the cost incurred by patients with HIV and AIDS related illnesses on in-patient 
days (PDE); and this is an institutional based retrospective data analysis to determine 
the costs in one of the hospital in Northern Cape.  
 
Data on expenditure was collected per month over a period of one year and put on the 
data sheet designed for cost analysis and determine the number of days the patient 
spent in hospital (length of stay).  
 
The study approach is quantitative, which is a formal, objective, systematic process for 
obtaining quantifiable information and this data is presented in a numerical form 
analysed through the use of statistics. This method is used to describe variables and 
test relationship and also examine the cause-and-effect between variables (Burns & 
Grove 2005:23). The study is on cost analysis of economic impact of HIV and AIDS on 
the length of stay .The importance and characteristics of quantitative research are the 
following: 
 
• It is more reliable and objective and can use statistics to generate findings. 
• It looks at relationships between variables and can establish cause and effect in 
a highly controlled circumstances. 
• It tests theories and hypothesis.  
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• It assumes that a sample is representative of population; subjectivity of 
researcher is recognised less and employs closed-ended questions, 
predetermined approaches and numerical data. 
•  Uses standards of validity and reliability; lastly uses unbiased approaches and 
employ statistical procedures.  
• It is an excellent way of finalising results and proving and disproving a 
hypothesis. Experiments can be difficult and expensive; and require a lot of time 
to perform (Creswell 2014:18). 
 
3.2 RESEARCH DESIGN  
 
Retrospective document review is a study design that was used to collect data from 
patient’s records which are an existing data that have been recorded. Retrospective 
document review are often called “chart reviews” because the data source are the 
medical records and are collected at one point in time. Retrospective study has three 
general types; case reports, case series and case-control. It can help focus the study 
question, clarify hypothesis, determine the appropriate sample size and identify the 
feasibility issues for prospective study (Polit & Beck 2008:342). This design was chosen 
because it is relatively easy, cheaper and economical to conduct. It is also cost 
effective, quick and a wide range of information may be collected. The design is useful 
for evaluating the relationship between exposures that are relatively fixed characteristics 
of individual and outcome (Abdool Karim et al 2007:144). Both exposures and outcome 
are determined simultaneously for subject as snapshot of the population at a certain 
point in time (Gordis 2008:28). The study design was limited to patients who were 
admitted with HIV-related illnesses from 1 April 2014 to 31 March 2015.   
 
3.2.1 Advantages of retrospective 
 
The method is inexpensive as it is uses existing records and allows studies of rare 
occurrences. It is easier to assess conditions where there is long latency between 
exposure and diseases; and can generate hypothesis that is then tested prospectively 
(Polit & Beck 2008:272-273). 
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3.2.2 Disadvantages of retrospective 
 
It relies on accuracy of written record or recall of individuals and the important data may 
not be available. It is also difficult to control bias and cofounders, no randomisation, no 
blinding; maybe impossible to access. The important information is restricted by statute 
or institutional regulations and it is difficult to establish cause-and-effect (Polit & Beck 
2008:272-273). 
 
3.3 MEASUREMENT 
 
Measurement is often regarded as being only means by which observations are 
expressed numerically in order to investigate the causal relations or association. It is 
argued that within quantitative research, the results that are shown can be strange. 
When measurement departs from theory it is likely to yield mere numbers and their 
neutrality makes them particularly sterile as a source of remedial suggestions. But 
numbers register the departure from theory within an authority and finesse that no 
qualitative technique can duplicate and that departure is often enough to start a search 
(Polit & Beck 2008:580).  
 
3.4 SETTING AND POPULATION OF THE STUDY 
 
3.4.1 Study area/setting 
 
One hospital was selected for cost analysis on the length of stay and only in the medical 
wards with inpatient admissions including patients with HIV and AIDS related illnesses. 
This hospital is based in the Northern Cape and is the only tertiary institution in the 
province. 
 
Population is the entire aggregation of cases in which the researcher was interested in 
for example the study population were all patients aged 15 to 49 years admitted with 
HIV and AIDS related illnesses for the period of one year from 1 April 2014 to 31 March 
2015. There are three medical wards where the study took place with a bed capacity of 
126 and an average of 35% of patients are admitted with HIV and AIDS related 
illnesses per month (DHIS 2014). Population is not restricted to human subjects, a 
population might consist of hospital records or files and the population comprises the 
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entire aggregate of record review of all patient’s files admitted with HIV and AIDS 
related illnesses aged 15 years to 49 years both males and females. The criteria that 
specify population characteristics are referred to eligibility criteria or inclusion criteria. 
Sometimes a population is defined as not having the same characteristics thus 
stipulating the exclusion criteria (Polit & Beck 2008:337-338). 
 
3.4.2 Sampling and sample 
 
The retrospective study can help to focus the study question, clarify the hypothesis, and 
determine an appropriate sample size. This is a hospital-based study focusing on 
clinical record review and the study population patient’s files admitted with HIV and 
AIDS related illnesses both gender ages 15 years to 49 years.  
 
Sampling is the process of selecting a portion of the population to represent the entire 
population so that inferences about population can be made and a sample is a subset of 
population elements. An element is the most basic unit about information is collected. A 
key consideration in assessing a sample in a quantitative study is its 
representativeness. A representative sample is one whose key characteristics closely 
approximate those of the population to be studied (Polit & Beck 2008:142).  
 
Sampling designs are classified as either probability or non-probability sampling. 
Probability sampling involves random selection of elements and is more respected 
because greater confidence can be placed in representativeness of probability 
sampling. A good choice of study subjects serves the vital purpose of ensuring that the 
findings in the study accurately represent what is going on in the population of interest 
(Hulley, Cummings, Browner, Grady & Newman 2012:27). In non-probability samples, 
elements are selected by non-random methods and there is no way that each element 
has been included; not every element has a chance of being included (Polit & Beck 
2008:337-339).  
 
The sample of the study were patients records from 01 April 2014 to 31 March 2015 
were entered on the data collection sheet and the sample size met the inclusion criteria 
the formula below calculated the sample size: 
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Sample size: To determine the required sample size for the study the formula that was 
used is as follows:        
 
                                   n = 2 (s)2    (zoc  + zβ )2 
                                                                   (MDC)2                
 
The value of n determined the number of admissions which were selected three 
hundred (300) and the sample size of 35% of the number of admissions = one hundred 
and five (105) admission files so proportional allocation to each stratum was applied 
and the 35% was considered in this study. This is a quota sampling as the researcher 
determined how many participants were required for each stratum (Polit & Beck 
2008:342).  
 
The sample reflects the true proportion in the population of individuals with certain 
characteristics (Creswell 2014:158). Methodologists have written discussions about 
underlying logic of sampling theory (Polit & Beck 2008:342). There were essential 
aspects of population based on two variables gender and medical diagnosis, the focus 
was to look into patient’s records of admitted with HIV and AIDS related illnesses and a 
total population of 300 files were purposefully selected. Only one file was excluded as 
the gender was not specified., leading to the sample size of 299 For cost analysis only 
105 patient’s files were audited and met the inclusion criteria (Polit & Beck 2008:342). 
 
3.4.3 Data collection methods and procedures  
 
The capacity of a retrospective study to adequately detect change and ascertain causes 
depends on how well the investigator can reconstruct the past from the vantage point of 
the present. The main purpose for collecting retrospective data is that such data provide 
a means of measuring change for either descriptive or explanatory purposes.The 
research seeks to describe the current status of an identified variable which is “Cost 
analysis”. The research was designed to provide systematic information about the 
phenomenon.The data on cost of average length of stay (ALOS) was collected through 
the following: 
 
1. A patient record review instrument was developed for data collection on the 
length of stay. 
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2. Administrative record review: data on full year’s hospital capital and recurrent 
cost for 1 April 2014–31 March 2015. The information was gathered from 
administrative section (fees office) of the hospital; admission books; midnight 
statistic book and Nootroclin (inpatient information management system). 
 
3.4.3.1 Data collection 
 
The daily statistics book gave detailed information about patient’s demography age; 
gender; date of admission and discharged date and these gave an indication of how 
many days the patient spent in hospital; reasons for admission (diagnosis). 
 
Confidentiality was maintained by using folder numbers instead of patient’s names. 
 
The study design had incorporated sample randomisation of 105 patient records as per 
inclusion criteria, the data was included as a sample and data collection sheet was 
developed to collect the information (see annexure F). 
 
The inclusion criteria were as follows: 
 
Only patients admitted with HIV-related illnesses aged 15 years to 49 years, admitted 
between the period of 1 April 2014 and 31 March 2015.   
 
A data collection instrument was developed to collect and record information such as 
folder numbers; gender; date of admission and discharge to determine the number of 
days spent in hospital and lastly individual costs. Instrument development was guided 
by extensive literature research and the final product was verified by the supervisor.  
Existing records are regarded as the important data source; hospital records; patient’s 
charts; physician’s examination sheet where the patient’s diagnosis is recorded. Pre-
existing records also permit on examination of trends over-time (Polit & Beck 2008:367-
368). 
 
This is a tertiary hospital with quadruple status as it was mentioned in chapter 1 and has 
768 usable beds. The area where the study took place was the three medical wards 
with 126 usable beds. The study sample or patient’s records were selected based on 
the inclusion criteria.  
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Date of admission 
 
This offered the statistical observations to determine date of entry in the hospital setting. 
Information on date of admission from patient’s files offered insight on the prevalence of 
HIV and AIDS related illnesses. 
 
Date of discharge 
 
This offered the statistical observation to determine the number of days the patient 
spent in hospital (inpatient days and patient day equivalent (PDE) which determines 
mathematical calculation of the cost per patient admission). Data collection was limited 
to the length of stay.  
 
Essential data was extracted from administrative records (admission books; midnight 
state books and Nootroclin information system) retrospectively and filled in a format 
developed for the purpose of the study. The extracted data was collected, entered into a 
data sheet and analysed in tool which was designed for the purpose. The cost per 
patient admission was determined by estimating the cost per patient day equivalent 
(PDE), patient day equivalent is an average cost per inpatient admission (inpatient 
days) and it monitors the effective and efficient management of a facility. PDE also 
measures the volume of patients seen in the hospital also account for all patients who 
do not spend a full day (from midnight to midnight) at the hospital as day patients, out-
patients and emergencies add to the workload of the hospital calculated in the 
equivalent number of 24-hours in-patients .  
 
3.4.3.2 Internal validity 
 
As validity is concerned with the soundness and effectiveness of the measuring 
instrument (Polit & Beck 2008:345), it must be asking whether the measuring instrument 
measures what it is intended to measure or not, and the degree of accuracy of the 
measurement. Internal validity of the study is the extent to which its design and data 
yields and allows to draw accurate conclusion about cause-and-effect and other 
relationship within the data. The specific intent of internal validity is to identify cause-
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and-effect relationship; in this project is to determine whether HIV and AIDS related 
illnesses has a significant cost effects on the length of stay (LOS).  
 
3.4.3.3 External validity 
 
It means the degree to which the results of the study can be generalized to other people 
and or other research settings. The study results apply beyond the study itself (Babbie 
& Mouton 2007:87). External validity concerns the representativeness of the study; the 
300 patient’s files which were retrieved represent the population of people admitted with 
HIV/AIDS related illnesses. After data collection has been completed and the results are 
generalised, the findings can be more readily applied to a broader group (Polit & Beck 
2008:302). 
 
3.4.4 Data summary collection sheet 
 
The data sheet was developed to collect information from 01 April 2014 to 31 March 
2015. The design of the sheet had the following information: folder number; gender both 
males and females; date of admission; date discharged; these dates determined the 
number of days spent in hospital and total costs. According to the audit the patient’s 
files were suggestive of 6.9 as the mean number of days per admission and the total 
costs. These were calculated cost per PDE per patient admission which was R2 957.10 
(DHIS 2014) and the cost of calculation used was R3 500 an average mean cost. 
 
3.4.5 Descriptive statistics 
 
Approaches of total cost determination for the average length of stay and average cost 
was calculated for each individual patient with HIV and AIDS related illness admission.  
 
Unit cost based: the cost information was available only on an aggregate basis for three 
medical wards. The aim of the unit cost was to allocate the hospital costs to care 
centers such as wards. Therefore to estimate the average costs per in-patient was a 
combination of two different methodologies. 
 
The main outcome measure was the average length of stay and cost per patient 
admission. The mean length of stay is 6 days and the mean cost per patient is R3 500. 
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The analysis of the cost on the length of stay was calculated through the use of patient 
day equivalent (PDE) cost calculation formula to indicate a general economic 
understanding on individual cost for an average length of stay per admission.  
 
In-patient: 
Total cost in-patient admission (TC) = (B) – average inpatient days 
PDE = R3 500 * ALOS = 6 days = S = 105 
 
Formula: 
C = Total Hospital Cost – R3 500 
L = Length of Stay – 6 days 
S = Percentage of sample − 105  
 
The cost per patient day was calculated on the basis of daily bed returns in the ward as 
inpatients. 
 
3.4.6 Data analysis 
 
Data captured was cleaned first before entered on the spreadsheet. It was analysed 
using both statistical NCSS10 software and manually. Results are presented in figures, 
tables and frequencies. An extensive data analysis report is shared in chapter 4. 
 
3.4.7 Ethical considerations 
 
The study involved records as a sample but the ethical principles were observed by the 
researcher. There are three primary ethical principles on which the standard ethical 
conduct in this research is based.  
 
• Beneficence − this is the principle which imposes an obligation for researcher to 
minimise harm and maximise benefit. 
• Respect for human dignity − this ethical right has two guiding principles self-
determination and full disclosure. Self-determination means that the participants 
are voluntarily participating to the study without being coerced and full disclosure 
is where the researcher fully describes the nature of the study to the participants. 
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• Justice − this principle of justice connotes fairness and equity; participants have 
the right to fair treatment and the right to privacy.  
 
There are procedures that are used to protect the participants when conducting a 
research. 
 
Confidentiality procedures  
 
Confidentiality through the use of folder numbers in collecting/retrieving folders was 
maintained throughout the study. Only the researcher and the Senior Administrative 
Clerk had access to the files. All retrieved files were kept in a lockable office.  
 
Anonymity  
 
This is the most secure means of protecting confidentiality where the researcher cannot 
link the participant from the data collected (Creswell 2014:92-98). On the data collection 
sheets only the folder registration numbers that were used to retrieve patient’s files 
folders. To maintain confidentiality a promise of confidentiality each researcher has an 
obligation to honour this, the information could not be shared with strangers, family 
members or any other person who was not involved in the research.  
 
There were steps that the researcher took to ensure that breach of confidentiality did 
not occur. 
 
Information for the study was obtained by the use of folder registration numbers that 
were not linked to names or surnames. An identification number was arranged to each 
participant’s folder. All files retrieved were kept in a lockable office and only the 
researcher and Senior Administrative Clerk had access. Access was restricted to the 
Record Clerks who retrieved the folders from the record office and other staff members 
did not have access to the contents of the file/folder. The Senior Record Officer ensured 
that the Record Clerks retrieved files using folder/registration numbers only. The 
registration folder numbers were used for the manual filing system at the hospital.  
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The Ethics Clearance was approved by Ethics Committee at University of South Africa 
(UNISA) (see annexure A). A letter and research proposal was submitted to the 
Provincial Review Committee (see annexure B), letter of approval from Provincial 
Health Research and Ethics Committee (see annexure C), letter to the Chief Executive 
Officer and approval (see annexure D), letter to the Medical Director who is responsible 
for medical records and approval (see annexure E). Identification of files when recording 
made use of codes or folder numbers. The study was not directly involved with the 
subjects but confidentiality, anonymity and respect were maintained as only patient’s 
records were used. The CEO was informed in writing about the purpose of the study; 
and what the researcher was intending to do.   
 
For the purpose of confidentiality no names were disclosed, records obtained were kept 
under strictest confidence in a lockable cabinet and only the researcher and Senior 
Records Clerk had access to the files. Identification of files when recording made use of 
codes or folder numbers.  
 
3.5 CONCLUSION 
 
This chapter focused on research design and methods, data collection and data 
collection tool, setting and population of the study, data analysis and the ethical 
considerations. In chapter 4, presentation of the findings will be discussed in details. 
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CHAPTER 4 
 
PRESENTATION OF FINDINGS 
 
4.1 INTRODUCTION 
 
This chapter discusses the data analysis and interpretation of the results. Data analysis 
is a process of bringing order, structure and meaning to the mass collected data and 
transforms data into findings (De Vos, Strydom, Fouché & Delport 2005:337). The 
purpose of this study was to determine the costs paid per patient admission and also 
established financial implications on the length of stay on patients with HIV/AIDS related 
illnesses who were admitted in the medical wards. 
 
In order to achieve the purpose the objectives of the study were: 
 
• To determine the costs of length of stay in caring for HIV and AIDS patients 
admitted in hospital. 
• To recommend cost containment strategies in caring for HIV and AIDS patients. 
 
4.2 DATA MANAGEMENT AND ANALYSIS 
 
Data analysis was done using both statistical NCSS10 software and manually. The 
sample of the study was 299 patient’s records and only 105 audited files were included 
in the cost analysis sample. The study contains of two sets of data, which will be 
presented as per analysis.  The numerical data were presented in the form of tables; 
graphs and descriptive statistics. The sample was large enough to calculate standard 
deviations from the mean or confidence intervals and also gave how many variations 
were there (Creswell 2014:162-164). Coding of inpatient admission and discharge dates 
were done as recorded in the patient files. The average length of stay in a hospital was 
calculated using date of admission and the date the patient was discharged from the 
hospital. Individual age of patients was not collected instead it was clustered as 15 to 49 
years and also data on CD4 strata was incomplete for analysis purposes. 
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4.3 RESULTS 
 
4.3.1 Patient characteristics 
 
All patients in this study were individuals of both gender (15–49 years) HIV positive, 
however, the status of antiretroviral treatment enrolment was not investigated or 
recorded due to the fact that during the record review there was minimal information 
recorded.  
 
The majority of study participants were males 66 %( n=197) as compared to females 
34% (n=102). The gender of the patients is shown in Table 4.1. 
 
Table 4.1 Gender (N=299) 
 
Gender Number Percentage (%) 
Male 197 66 (59.82-70.65%) 
Female 102 34 (29.03-39.83%) 
Total 299 100.0% 
 
4.3.2 Average length of stay 
 
The average length of stay in hospital is a statistical calculation often used for planning 
purposes and measures the main outcome of the patient stay. It also refers to the 
average number of days when the client is admitted in hospital before discharge. It is a 
proxy indicator because ideally it should only include inpatient days for those clients 
separated during the reporting month and it is used in all hospitals and Community 
Health Centres (CHCs) with inpatient beds (NIDS 2015). The majority of participants 
(58.53%) stayed in hospital between 1-3 days followed by 20.40 % staying between 1-9 
days. Only 1% of participants stayed more than 13 days in hospitals. The median length 
of stay (LOS) for all patients was 3 days [Interquartile (IQR): 1–5] as indicated in Table 
4.2.  
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Table 4.2 Average length of stay in hospital (ALOS) (N=299) 
 
Average length of stay in hospital Percentage (%) 
1-3 days 58.53  (52.83-64.01) 
1-6 days 17.39  (13.48-22.14) 
1-9 days 20.40  (16.19-25.38) 
1-12 days 2.68  (13.38-52.79) 
13 days 1.03  (3.32-30.83) 
 
 
The general recurrent inpatient day costs were obtained from the hospital electronic 
billing system that uses a computed standard formula to estimate daily average costs. 
The total costs of patients admitted due to HIV related illnesses was calculated based 
on the standard costing provided by the hospital, with the costs recorded to be 
2,691,500 for all 105 patients included in the study.  The average (arithmetic mean) of 
total costs amongst the study population was R1597.32 (see Table 4.3).  
 
 
 
Figure 4.1   Cost per patient 
 
 
4.3.3 Patient costing 
 
The calculation was done based on the information which is reflecting on the data 
sheet. Out of 300 sampled patient folders a total of hundred and five 35% (105) 
0
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1 (R0 – R17500) 2 (R17501 – 31500)  3 (R31501 – R49000) 
4 (R49001 & above) Total
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patient’s folders were audited individually to ascertain their credibility for the study. The 
total number of days (length of stay − LOS) spent during the patient’s hospitalisation of 
all who were admitted with HIV-related illnesses/diseases aged 15 to 49 years over a 
period 1 year. These patients spent 769 days at a unit cost expressed as the patient 
day equivalent (PDE) of R3 500. PDE is an indicator measure on how the available 
resources to the hospital are being spent and is a marker of the efficiency of the hospital 
as a whole. It is a composite marker in that it links financial data with related service 
data from hospital admissions and out-patients. The indicator measures the average 
cost per patient per day and is expressed in the South African currency (Rands) per 
patient day equivalent. Cost per patient day (PDE) reflects the efficiency of the hospital 
whether that particular hospital is being optimally managed. The cost per patient was 
directly proportional to increase in length of stay as indicated in Figure 4.1.   
 
Table 4.3 Cost calculation (N=105) 
 
Number of days Total Unit cost Total cost 
8*23 184 3 500 644 000 
18*1 18 3 500 63 000 
10*2 20 3 500 70 000 
6*30 180 3 500 630 000 
18*1 18 3 500 63 000 
23*1 23 3 500 80 500 
5*1 5 3 500 17 500 
11*1 11 3 500 38 500 
14*1 14 3 500 49 000 
4*1 4 3 500 14 000 
7*34 238 3 500 833 000 
105 787 3 500 2 691 500 
 
Summary:  
Number of days spent in hospital (LOS) x Patient Day Equivalent (PDE) 
= 769 x R3 500 
    Total      = R2 691 500 
 
This is the amount of money which was spent for only hundred and five (105) patients 
who were admitted over a period of one year. From 105 patient files the total 
expenditure was R2 691 500, it is evident that there was increased number of days 
spent and the cost incurred increased (see Table 4.3).  
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4.3.4 Cost analysis 
 
Only 105 audited patient folders were included for cost analysis. The cost analysis was 
done based on the number of files that were audited based on the average length of 
stay and the patient day equivalent. Cost-effectiveness analysis compares decision 
options in terms of monetary. For this study the cost analysis of HIV and AIDS is related 
to hospitalisation when calculating the cost per patient admission.  
 
Cost-effectiveness analysis involves identification of costs of decision options and 
evaluation of these costs and in many cases it determines health outcome decision 
options. Once the data on costs and outcomes had been identified then cost per patient 
admission was determined.   
 
4.3.5 Bivariate analysis 
 
Bivariate analysis between ALOS and cost intervals showed that patients who stayed 
between 10–13 days in a hospital due to HIV and AIDS related conditions/illnesses had 
significantly higher hospitalisation costs compared to those hospitalised for less than 
four days. This pattern of increasing in-patient costs per length of stay is to be expected 
for several reasons. One of the reasons is that tertiary hospitals are intended for 
treatments that are complex and severe medical conditions requiring more sophisticated 
care with high costs.   
 
Table 4.4 Bivariate analysis between gender and average length of stay (N=299)  
 
Gender Average Length of Stay (ALOS) 
Total 
1-3 days >3 days 
Female 51 (50%) 51 (50%) 102 
Male 124 (63%) 73 (37%) 197 
Total 175 (59%) 124 (41%) 299 
 
Bivariate analysis between ALOS and gender demonstrated that the majority of males 
spent 1-3 days as compared to females who had an equal number for both categories  
Approximately 50% of females (51 of 102), had an average length of stay between 1–3 
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days in a hospital compared to 63% (124 of 197) of males. However, this difference in 
average length of stay (ALOS) by gender was statistically different (p-value=0.0062).  
 
Table 4.5 Measure of association between gender and in-patient costs (N=299) 
 
Gender 
Cost intervals 
R0-R17 
500 
 
R17 501- 
R31 500 
R31 501- 
R49 000 
>R49 001 Total P-value 
Females 56 41 4 1 102 0.006 
Males 141 54 1 1 197  
Total 197 95 5 2 299  
 
Comparative analysis of in-patient costs and gender illustrates that a higher proportion 
of patients amongst females had costs of more than R31 501 compared to males. This 
is due to a higher number of female patients who stayed longer in hospital. The 
difference of females having higher in-patient costs was statistically significant with a p-
value of 0.006 (P ≤ 0.05). 
 
Table 4.6 Analysis of frequency costs (N=299) 
 
Costs Frequency Percent (%) 
R0-R17 500 197 65.89%  (60.29–71.07%) 
R17 501-R31 500 95 31.77%  (26.72–37.30%) 
R31 501-R49 000 5 1.67%  (6.94–39.73%) 
R49 001-R80 500 2 0, 6%   (1.66–26.55%) 
 
Table 4.6 shows different values with different cost categories. The majority of 
participants 65.89% (n=197) costed the hospital from R0–R17 500 as compared to. 
31.77 %( n=95) who costed the hospital from R17 501−R31 500 and followed by the 
cost from R31 501–R49 000 by 1.67% (n=5). Lastly the costs are R49 001–R80 500 
(n=2) and this account for 6.69% of total sample.      
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Table 4.7  Analysis on ALOS and cost intervals (N=299) 
 
 
ALOS 
COST INTERVALS 
TOTAL 
R0-R17 500 
R17 500-
R31 500 
R31 500-
R49 000 
>R49 001 
1-3 days 175 0 0 0 175 (58.5%) 
4-6 days 22 30 0 0 52 (17.3%) 
7-9 days 0 61 0 0 61 (20.4%) 
10-13 days 0 4 5 2 11 (3.6%) 
Total  197 95 5 2 299 (100.0%) 
 
The majority of the participants 58.5% (n=175) spent 1-3 days as compared to 20.4% 
(n=61) who spent 7-9 days and 17,3% (n=52) who spent 4-6 days in hospital as detailed 
in Table 4.7 . The huge number (n=197) on the length of stay cost the hospital attribute 
large amount of money (197 x R3500=R672 000) and this has been calculated as a 
single episode. 
 
4.4 DISCUSSION 
 
The study was conducted within the Tertiary Hospital (public facility). The inclusion 
criteria were files of patients admitted with HIV and AIDS related illnesses within ages 
15–49 years. The hospital has 775 active beds and Internal Medicine has 126 beds 
where the study was conducted. The study approach was retrospective with some files 
becoming untraceable due to loss or transfer of patients to the primary health care 
facilities. A total of 300 patient folders were reviewed as part of the study, but only 299 
were included in the sample. For costing analysis, 105 files were included as they were 
audited for accurate costs. The data consisted of two sets, the 299 and 105 figures.  
 
4.4.1 Patient characteristics 
 
All patients in this study were individuals of both gender (15–49 years) HIV positive, 
however, the status of antiretroviral treatment enrolment was not investigated or 
recorded due to the fact that during the record review there was minimal information 
recorded. The majority of study participants were males with male-to-female ratio of 
1.91 (195/102). The findings are in contrast with Sia, Onadja, Nandi, Foro and Brewer 
(2013:8) who stated that within the Sub-Sahara region, women  as compared to men 
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are disproportionately at risk of acquiring HIV although gender inequalities varies by 
countries. Again, in the study by Mitha et al (2014:215) there were more males (65.2%) 
than females (34,8%) who were HIV positive  
 
Individual age of patients were not collected instead they were clustered as 15 to 49 
years. The data on CD4 strata was incomplete for analysis purposes as in the majority 
of sampled patient folders the CD4 results were not recorded, hence the researcher did 
not analysed CD4 counts. 
 
4.4.2 Inpatient costs 
 
The general recurrent inpatient day costs were obtained from the hospital electronic 
billing system that uses a computed standard formula to estimate daily average costs. 
The total costs of patients admitted due to HIV related illnesses was calculated based 
on the standard costing provided by the hospital, with the costs recorded to be  
R2 691 500 for all 105 patients included in the study. The findings correlate with the 
findings of Long et al (2016:8) where one HIV positive costed the South African 
government R 14 554.00 for a 3 day stay in a public hospital. The similar finding was 
shared by Yengopal and Naidoo (2004:32) when calculating the cost of inpatient care 
for each HIV positive patient in Cape Town, which was R18 765.76. 
 
The tables presented an easy overview of the results where it showed the differences 
on variables for example there were more males admitted than females. Costs incurred 
by patients with HIV related illnesses were more than patients who were not having HIV 
related illnesses. 
 
According to Nijhawan, Kitchell, Etherton, Duarte, Halm and Jain (2015:465-473) 
readmissions can be prevented if optimal patient care is rendered during the initial 
admission. Caring for these patients cost a lot of money that why the suggestion would 
be development of intervention strategies that would prevent the number of admission 
(Nijhawan et al 2015:465-473). 
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4.4.3 Average length of stay 
 
In this study, the average length of stay (ALOS) for all patients was 3 days [Interquartile 
(IQR):1–5], whereas Yengopal and Naidoo (2004:36) reported the average length of 
stay in hospital was 9 days. 
 
 Fifty percent (50%) of females (51 of 102), had an average length of stay between 1–3 
days in a hospital compared to 63% (124 of 197) of males. However, this difference in 
ALOS by sex was marginally  statistically different (p-value=0.062) and the findings are 
similar to Catumbela et al (2015:10), where males stay longer in hospitals than females 
although there is reported declining figures on admission due to the available support 
structures in communities. 
 
However, Goncalves and Ferreira (2013:2) reported that there was no statistically 
significant difference between males and females and that the average length of stay for 
HIV positive patients was 29.6 days. Long, Fox, Sauls, Evans, Sanne and Rosen 
(2016:7), reported that the overall mean length of stay was 9.3 days and the longest 
average length of stay was 13.2 days.  
 
The findings were similar to most studies comparing costs between HIV positive and 
HIV negative individuals with in-patient costs being higher in the former. The current 
study showed the total costs of patients with longer stay in a hospital to be higher 
compared to patients who stayed less than 3 days (Yengopal & Naidoo 2004:38; Meyer-
Rath et al 2013:327; Catumbela et al 2015:8). 
 
Coding of inpatient admission and discharge dates were done as recorded in the patient 
files. The average length of stay in a hospital was calculated using date of admission 
and the date the patient was discharged from the hospital.Hospitals admissions can 
also be reduced if patients have access to treatment at early stages (Meyer-Rath et al 
2013:325).  Worldwide, the introduction of antiretroviral therapy (ART) has resulted in a 
large decrease in frequency, average length of hospital stay and cost of patient per stay 
(Meyer-Rath et al 2013:322).   
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4.4.4 Acceptance/rejection of the hypotheses 
 
Based on the findings the hypothesis is accepted that length of stay was a significant 
factor on patient admission. The average length of stay (ALOS) for all patients was 3 
days [Interquartile (IQR):1–5]. Fifty percent (50%) of females (51 of 102), had an 
average length of stay between 1–3 days in a hospital compared to 63% (124 of 197) of 
males. However, this difference in ALOS by gender was marginally statistically different 
(p-value=0.062). 
 
4.5 CONCLUSION 
 
This chapter discussed data analysis, study results, patient characteristics, and average 
length of stay, patient costing, cost analysis and bivariate analysis. An in-depth 
discussion and presentation of the results were done. 
 
In chapter 5, conclusion, scope, limitations and recommendations will be discussed.   
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CHAPTER 5 
 
CONCLUSION, SCOPE, LIMITATIONS AND RECOMMENDATIONS 
 
5.1 INTRODUCTION 
 
Chapter 4 was the presentation and analysis of data and this chapter will focus on the 
conclusion, scope and limitation of the study and lastly coming up with 
recommendations. 
 
5.2 RESEARCH DESIGN AND METHOD  
 
A quantitative approach was used to collect data; analysed; interpretation and report 
writing. Purposeful sampling and data collection was done using data collection sheet.  
This was a retrospective cost analysis data from in-patients records (record review) of 
ages from 15 years to 49 years both gender.  
 
Patient’s folder numbers were obtained from admission books in the three wards and an 
audit was conducted in order to determine the length of stay. The study reviewed the 
cost incurred by patients with HIV and AIDS related illnesses on in-patient day’s 
equivalent (PDE); and this is an institutional based retrospective data analysis to 
determine the costs in one of the hospital in Northern Cape.  
 
5.3 SUMMARY OF THE RESEARCH FINDINGS  
 
This study found that males (63%) with HIV & AIDS related illnesses had longer 
average length of stay in a hospital compared to females. The study done by Catumbela 
et al (2015:4) had some similarities as they also reported that the median LOS was 
significantly higher in men by spending 12 days and females staying 10 days in 
hospitals. Longer admissions affect the financial viability of households especially if the 
breadwinner is admitted. The findings are similar to the majority of studies done in the 
Sub-Sahara region (Bachmann & Booysen 2003:4; Catumbela et al 2015:4; Thomas et 
al 2007:410). 
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The health care costs incurred for HIV and AIDS hospital admissions were high in this 
study and were similar to the study done in Kenya by Guinness, Arthur, Bhatt, Achiya, 
Kariuki and Gilks (2002:904). Costs and length of stay with HIV/AIDS hospitalisation 
has put strain on the limited resources and compromise the quality of care.The findings 
are similar to the study done by Schoeman (2009:48) where the costs of hospitalising 
HIV-positive children were significantly high which increased the financial burden on the 
already restricted health resources.  
 
5.4 CONCLUSION 
 
The study looked into the costs implication of average length on in-patient costs 
amongst HIV and AIDS patients. As the HIV and AIDS epidemic continues to advance 
in our community, economic implications are already apparent in our health care 
system. 
 
Admission of HIV positive patients represents a significant medical care cost in the 
public health sector. The average cost for patients with short-term stay was relatively 
less compared to patients staying longer in a hospital. The total number of in-patient 
days (ALOS) of an individual can directly influence the average costs per in-patient 
care. The findings indicate that the mean average length of stay for HIV positive 
individuals in this study  was significantly lower at a mean of 3 days than the findings in 
a study  that was conducted in the children’s hospital in South Africa with an average 
length of stay which was 9 days (Yengopal & Naidoo 2004:38). 
 
Analysis of costs of HIV-associated care illustrated an important picture of the financial 
implication of HIV and AIDS in public hospitals including patient care costs. The 
association of longer in-patient stays versus patient care costs due to HIV and AIDS 
calls for better management of patients at primary healthcare level and community level 
to minimise long hospital stays. 
 
Females incurred higher in-patient costs compared to male patients. This difference can 
be explained as literature has demonstrated that females are highly affected than males 
globally.  
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The study provides cost analysis with information as how much budget was used up in 
providing in-patient costs for HIV and AIDS. The study also illustrates the financial 
impact of lengthy in-patient stay on the already constricted public funding thus providing 
the much needed baseline information for health planners in future planning and biding 
for adequate budget.   
 
5.5 SCOPE OF STUDY 
 
The scope of the study was of a limited nature as it was done in one hospital at a 
Masters level which is of limited scope.  It was only limited to one dependent variable 
the average length of stay (ALOS). Furthermore, the dissertation is of limited scope as 
stated in the University research policy. 
 
5.6 RECOMMENDATIONS 
 
The study dealt with documents of patients and there were no interviews that were 
conducted but the researcher recommends based on the findings and the literature of 
the study In order to decrease the average costs on hospital care of HIV infected 
patients and also identify cost containment strategies in caring for HIV positive and 
AIDS patients, the following are recommended: 
 
5.6.1 Practice  
 
• In terms of patient care and home care, hospitalisation can be greatly reduced 
through home-based care programme, linked to the primary health care (PHC) 
re-engineering program which advocates for preventative efforts over curative 
approach. The Minister of Health in South Africa is advocating for re-engineering 
PHC so as to reduce the high number of patients who are hospitalised (DOH 
2012). 
 
5.6.2 Nursing research 
 
• For cost-effectiveness analysis measurement, further research need to be 
conducted in understanding factors associated with high in-patient costs of HIV 
and AIDS patients. 
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• More research studies should be conducted that will be targeted towards 
preventive, curative and rehabilitative aspects to reduce the burden of patient’s 
admission. 
• To conduct a study using different research methodologies and compare the 
economic impact between HIV positive and HIV negative patients. 
 
5.7 CONTRIBUTIONS OF THE STUDY 
 
The study gave a clear indication of the exorbitant costs incurred by HIV/AIDS related 
admissions. The understanding of factors affecting HIV-related hospitalisation would 
help to optimise resource allocation and could also reduce the high cost of 
hospitalisation. The information gathered on costs; treatment and care for these patients 
might guide the planners for adequate budgeting.  
 
5.8 LIMITATIONS OF THE STUDY 
 
The analysis of costs had a number of limitations, first of all the economic component 
was retrospective as a result some patient expenditure records were not be traceable 
resulting in an incomplete sample although no obvious bias lead to this.  
 
There was a possibility of not getting files as it should due to the system of missing files 
and records clerks felt overwhelmed of additional work they have to do. 
 
Methodology had limitation as only documents were reviewed for the study. The sample 
size did not reflect or determine the exact budget allocations for the hospital. 
 
The study was done using retrospective design and there were no interviews that were 
conducted which might come out with strategies to reduce the costs. Recommendations 
are based on the findings and also literature. 
 
5.9 CONCLUDING REMARKS 
 
The study findings has managed to analyse the cost involved on the length of stay of 
HIV and AIDS patients in a public hospital. The findings also showed that in-patient care 
costs were directly proportional to length of stay with higher costs for HIV and AIDS 
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patient management care. The findings are consistent with other studies regarding 
higher economic implications of care for HIV infected persons being almost as twice as 
people who are HIV negative due to longer periods of hospitalisation.    
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NAME: N.O GUMBO                                     STUDENT NUMBER: 646 – 120 – 4 
Title: Analysis of the economic impact of HIV and AIDS on the length of stay in 
one hospital in the Northern Cape 
The purpose of the study is to provide information on how the length of stay of HIV and 
AIDS patients can affect the costs of the overall budget of Internal Medicine Discipline. 
The study will also determine the burden incurred by the Discipline in admitting these 
patients instead them being treated at Day Care Canters 
1. Data collection sheet AIDS cases by  F/Numbers; Gender; Date of 
Admission; Date Discharged;  Number of Days & Total Costs 
Table: Year - April 2014 – March 2015 
 
 Folder 
Number  
Male Female Code  Date of 
Admission 
Date 
Discharged 
Number 
of Days 
Total Costs 
1 23667942  x ICD 
10 
27/07/2014 03/08/2014 6 R21 000 
2 20238754 x  ICD10 19/09/2014 25/09/2014 6 R21 000 
3 30437404 x  ICD10 26/09/2014 02/10/2014 6 R21 000 
4 31532369 x  ICD10 26/09/2014 01/10/2014 5 R17 500 
5 21031133 x  ICD10 16/04/2014 20/04/2014 4 R14 000 
6 31104854  x ICD10 27/06/2014 02/07/2014 6 R21 000 
7 31482425  x ICD10 06/09/2014 12/09/2014 6 R21 000 
8 23650609 x  ICD10 05/04/2014 08/04/2014 4 R14 000 
9 24179764  x ICD10 25/09/2014 02/09/2014 7 R24 500 
10 25421140 x  ICD10 8/12/2014 15/12/2014 7 R24 500 
11 24003147  x ICD10 16/12/2014 22/12/2014 6 R21 000 
12 26731752  x ICD10 04/12/2014 27/12/2014 23 R80 500 
13 21066790  x ICD10 21/11/2014 05/12/2014 14 R49 000 
14 22977490 x  ICD10 22/10/2014 08/11/2014 18 R63 000 
15 20243197 x  ICD10 20/03/2015 27/03/2015 6 R21 000 
16 22762173  x ICD10 15/01/2015 21/01/2015 6 R21 000 
17 31643174  x ICD10 25/11/2014 01/12/2014 6 R21 000 
18 22145841 x  ICD10 08/08/2014 15/08/2014 7 R24 500 
19 21819851  x ICD10 16/08/2014 23/08/2014 7 R24 500 
20 31499601 x  ICD10 22/08/2014 30/08/2014 8 R28 000 
21 30752570 x  ICD10 03/09/2014 11/09/2014 8 R28 000 
22 30946123 x  ICD10 11/092014 18/09/2014 7 R24 500 
23 31544855  x ICD10 02/09/2014 09/09/2014 7 R24 500 
24 20486908  x ICD10 05/09/2014 14/09/2014 9 R31 500 
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 Folder 
Number  
Male Female Code  Date of 
Admission 
Date 
Discharged 
Number 
of Days 
Total Costs 
25 22065551 x  ICD10 17/09/2014 26/09/2014 10 R35 000 
26 31415557  x ICD10 16/09/2014 24/09/2014 8 R28 000 
27 29683386 x  ICD10 01/09/2014 10/09/2014 9 R31 500 
28 21204690 x  ICD10 20/09/2014 28/09/2014 7 R24 500 
29 31103088 x  ICD10 10/11/2014 19/11/2014 8 R28 000 
30 31617509 x  ICD10 07/11/2014 16/11/2014 9 R31 500 
31 31597792  x ICD10 02/11/2014 11/11/2014 9 R31 500 
32 20157566 x  ICD10 05/11/2014 12/11/2014 8 R28 000 
33 316174426 x  ICD10 08/11/2014 16/11/2014 8 R28 000 
34 31619117  x ICD10 03/11/2014 14/11/2015 11 R38 500 
35 22475495 x  ICD10 20/10/2014 29/10/2014 8 R28 000 
36 30587836 x  ICD10 15/11/2014 22/11/2014 7 R24 500 
37 30587836 x  ICD10 20/11/2014 27/11/2014 6 R21 000 
38 21131446 x  ICD10 11/11/2014 19/11/2014 8 R28 000 
39 24561615 x  ICD10 17/11/2014 26/11/2014 9 R31 500 
40 31626732 x  ICD10 05/11/2014 11/11/2014 6 R21 000 
41 31638257  x ICD10 20/11/2014 28/11/2014 7 R24 500 
42 22134050 x  ICD10 21/11/2014 29/11/2014 8 R28 000 
43 32241198  x ICD10 03/12/2014 11/12/2014 9 R31 500 
44 22070593  X ICD10 16/12/2014 25/12/2014 10 R35 000 
45 22025324 x  ICD10 10/12/2014 17/12/2014 6 R21 000 
46 25720154 x  ICD10 14/12/2014 20/12/24 6 R21 000 
47 31665078 x  ICD10 06/12/2014 14/12/2014 8 R28 000 
48 31624430 x  ICD10 15/12/2014 23/12/2014 8 R28 000 
49 23814031  x ICD10 09/12/2014 17/12/2014 8 R28 000 
50 22411987 x  ICD10 13/12/2014 20/12/2014 7 R24 500 
51 25421140 x  ICD10 05/12/2014 11/12/2014 6 R21 000 
52 31356173 x  ICD10 15/12/2014 22/12/2014 7 R24 500 
53 21388707  x ICD10 07/12/2014 13/12/2014 6 R21 000 
54 31632144 x  ICD10 10/10/2014 17/10/2014 6 R21 000 
55 31726656 x  ICD10 13/10/2014 20/10/2014 7 R24 500 
56 21066790 x  ICD10 02/10/2014 09//10/2014 8 R28 000 
57 22584965 x  ICD10 11/10/2014 18/10/2014 7 R24 500 
58 31639644  x ICD10 13/10/2014 20/10/2014 7 R24 500 
59 31514078  x ICD10 05/10/2014 13/10/2014 8 R28 000 
60 24030744 x  ICD10 15/10/2014 23/10/2014 8 R28 000 
61 25767625  x ICD10 06/10/2014 14/10/2014 7 R24 500 
62 31643174  x ICD10 03/10/2014 11/10/2014 8 R28 000 
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 Folder 
Number  
Male Female Code  Date of 
Admission 
Date 
Discharged 
Number 
of Days 
Total Costs 
63 31647604  x ICD10 09/10/2014 17/10/2014 8 R28 000 
64 24381154 x  ICD10 11/10/2014 18/10/2014 7 R24 500 
65 31651649  x ICD10 22/10/2014 29/10/2014 7 R24 500 
66 22128359  x ICD10 14/10/2014 21/10/2014 7 R24 500 
67 25128422 x  ICD10 19/10/2014 27/10/2014 8 R28 000 
68 31654411 x  ICD10 06/10/2014 13/10/2014 6 R21 000 
69 31447915  x ICD10 04/10/2014 10/10/2014 6 R21 000 
70 20008793  x ICD10 12/10/2014 19/10/2014 7 R24 500 
71 21094933  x ICD10 10/10/2014 17/10/2014 6 R21 000 
72 31561608 x  ICD10 22/10/2014 29/10/2014 7 R24 500 
73 24897365 x  ICD10 14/10/2014 21/10/2014 6 R21 000 
74 31654395  x ICD10 11/10/2014 20/10/2014 9 R31 500 
75 31654395  x ICD10 07/10/2014 15/10/2014 7 R24 500 
76 20243192 x  ICD10 09/10/2014 17/10/2014 6 R21 000 
77 30233688 x  ICD10 05/10/2014 13/10/2014 8 R28 000 
78 31658701 x  ICD10 13/10/2014 20/10/2014 7 R24 500 
79 31337884  x ICD10 02/06/2014 11/06/2014 9 R31 500 
80 20923087 x  ICD10 16/06/2014 23/06/2014 7 R24 500 
81 24307381  x ICD10 05/06/2014 14/06/2014 8 R28 000 
82 23671274 x  ICD10 07/06/2014 15/06/12 8 R28 000 
83 31376148 x  ICD10 15/07/2014 23/07/2014 8 R28 000 
84 30832620  x ICD10 16/05/2014 23/05/2014 6 R21 000 
85 20786356  x ICD10 22/05/2014 28/05/2014 6 R21 000 
86 24525321   x  ICD10 15/07/2014 21/07/2014 6 R21 000 
87  22304786  x ICD10 03/07/2014 09/05/2014 6 R21 000 
88 31342165  x ICD10 13/07/2014 20/07/2014 7 R24 500 
89 20486759  x ICD10 23/07/2014 29/07/2014 6 R21 000 
90 30820039 x  ICD10 15/07/2014 22/07/2014 7 R24 500 
91 22290092 x  ICD10 22/04/2014 29/04/2014 7 R24 500 
92 31150402  x ICD10 10/04/2014 17/04/2014 6 R21 000 
93 23046832  x ICD10 11/04/2014 18/04/2014 7 R24 500 
94 31065212 x  ICD10 06/04/2014 12/04/2014 6 R21 000 
95 31232465  x ICD10 09/04/2014 16/04/2014 7 R24 500 
96 21593892 x  ICD10 16/04/2014 23/04/2014 7 R24 500 
97 31236623 x  ICD10 03/04/2014 10/04/2014 7 R24 500 
98 25821612 x  ICD10 05/04/2014 12/04/2014 7 R24 500 
99 21122106  x ICD10 13/04/2014 21/04/2014 8 R28 000 
100 24448953  x ICD10 06/04/2014 13/04/2014 7 R24 500 
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101 24440257 x  ICD10 09/04/2014 15/04/2014 6 R21 000 
102 24783540    x ICD10 05/05/2014 12/05/2014 7 R24 500 
103 31431703 x  ICD10 16/05/2014 23/05/2014 7 R24 500 
104 23671274 
(June 14) 
x  ICD10 11/06/2014 17/06/2014 6 R21 000 
105 31065147 x  ICD10 19/06/2014 26/06/2014 7 R24 500 
 TOTAL 
COSTS 
      R2 730 000 
106 20341699 x  ICD9 22/06/2014 25/06/2014 3 R10 500 
107 31361249  x ICD9 05/06/2014 7/06/2014 2 R7 000 
108 25002262 x  ICD9 04/06/2014 8/06/2014 4 R14 000 
109 24113761 x  ICD9 17/06/2014 20/06/2014 3 R10 500 
110 30195317  x ICD9 13/06/2014 16/06/2014 3 R10 500 
111 24940371 x  ICD9 01/06/2014 04/06/2014 3 R10 500 
112 30378095 
(May) 
x  ICD9 08/05/2014 11/05/2014 3 R10 500 
113 24046120  x ICD9 13/05/2014 15/05/2014 2 R7 000 
114 30050827  x ICD9 06/05/2014 09/05/2014 3 R10 500 
115 22938757 x  ICD9 11/05/2014 14/05/2014 3 R10 500 
116 31475841 x  ICD9 17/05/2014 20/05/2014 3 R10 500 
117 20575387 x  ICD9 02/05/2014 06/05/2014 4 R14 000 
118 31460694  x ICD9 15/05/2014 17/05/2014 2 R7 000 
119 23071061 x  ICD9 14/05/2014 18/05/2014 4 R14 000 
120 20404729 x  ICD9 23/05/2014 26/05/2014 3 R10 500 
121 21711767 x  ICD9 04/05/2014 07/05/2014 3 R10 500 
122 30469910 x  ICD9 02/05/2014 05/05/2014 3 R10 500 
123 21619515 
(Dec.) 
x  ICD9 03/12/2014 07/12/2014 4 R14 000 
124 22955868  x ICD9 16/12/2014 19/12/2014 3 R10 500 
125 31679947  X ICD9 06/12/2014 10/12/2014 4 R14 000 
126 20557492 x  ICD9 13/12/2014 16/12/2014 3 R10 500 
128 23578933  x ICD9 03/12/2014 05/12/2014 2 R7 000 
129 20879748  x ICD9 11/12/2014 14/12/2014 3 R10 500 
130 23242092 x  ICD9 08/12/2014 11/12/2014 3 R10 500 
131 24046120 x  ICD9 13/12/2014 15/12/2014 2 R7 000 
132 31691801 x  ICD9 06/12/2014 09/12/2014 3 R10 500 
133 25978248  x ICD9 07/12/2014 09/12/2014 2 R7 000 
134 25774266 x  ICD9 19/12/2014 21/12/2014 2 R7 000 
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135 20645289  x ICD9 25/12/2014 28/12/2014 3 R10 500 
136 20138420 x  ICD9 02/12/2014 06/12/2014 4 R14 000 
137 30437099  x ICD9 10/12/2014 13/12/2014 3 R10 500 
138 31705841 x  ICD9 16/12/2014 19/12/2014 3 R10 500 
139 20879748 x  ICD9 04/12/2014 07/12/2014 3 R10 500 
140 28934800 x  ICD9 20/12/2014 23/12/2014 3 R10 500 
141 20648162 x  ICD9 11/12/2014 14/12/2014 3 R10 500 
142 24830804  x ICD9 26/12/2014 28/12/2014 2 R7 000 
143 31447915 x  ICD9 09/12/2014 12/12/2014 3 R10 500 
144 31710650 x  ICD9 12/12/2014 15/12/2014 3 R10 500 
145 31535107 (End 
Dec) 
 x ICD9 22/12/2014 24/12/2014 2 R7 000 
146 20551404 
(Jan. 15)  
 x ICD9 03/01/2015 05/01/2015 2 R7 000 
147 31702442 x  ICD9 08/01/2015 11/01/2015 3 R10 500 
148 21516323 x  ICD9 16/01/2015 19/01/2015 3 R10 500 
149 30064869  x ICD9 22/01/2015 25/01/2015 3 R10 500 
150 31686173 x  ICD9 12/01/2015 16/01/2015 4 R14 000 
151 21664313 x  ICD9 06/01/2015 08/01/2015 2 R7 000 
152 31705791  x ICD9 14/01/2015 17/01/2015 3 R10 500 
153 31704661 x  ICD9 10/01/2015 13/01/2015 3 R10 500 
154 31706112 x  ICD9 07/01/2015 10/01/2015 3 R10 500 
155 31397615 x  ICD9 22/01/2015 24/01/2015 2 R7 000 
156 21871249  x ICD9 13/01/2015 16/01/2015 3 R10 500 
157 31706203 x  ICD9 09/01/2015 12/01/2015 3 R10 500 
158 30730165 x  ICD9 12/01/2015 15/01/2015 3 R10 500 
159 31706864 x  ICD9 19/01/2015 21/01/2015 2 R7 000 
160 31669237  x ICD9 11/01/2015 14/01/2015 3 R10 500 
161 24248601 x  ICD9 01/01/2015 05/01/2015 4 R7 000 
162 30831077 x  ICD9 05/01/2015 08/01/2015 3 R10 500 
163 20736112 x  ICD9 16/01/2015 20/01/2015 4 R14 000 
164 31722275  x ICD9 23/01/2015 26/01/2015 3 R10 500 
165 25534694 x  ICD9 19/01/2015 23/01/2015 4 R14 000 
166 23805401 x  ICD9 17/01/2015 20/01/2015 3 R10 500 
167 20488490 x  ICD9 09/01/2015 12/01/2015 3 R10 500 
168 24738635 x  ICD9 10/01/2015 13/01/2015 3 R10 500 
169 21230537  x ICD9 03/01/2015 06/01/2015 3 R10 500 
170 31732225 x  ICD9 07/01/2015 09/01/2015 2 R7 000 
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171 30730162 x  ICD9 19/01/2015 21/01/2015 2 R7 000 
172 21028352 x  ICD9 25/01/2015 28/01/2015 3 R10 500 
173 29781820  x ICD9 02/01/2015 06/01/2015 4 R14 000 
174 21724012  X ICD9 10/01/2015 13/01/2015 3 R10 500 
175 23571656 x  ICD9 16/01/2015 19/01/2015 3 R10 500 
176 21071931 x  ICD9 04/01/2015 07/01/2015 3 R10 500 
177 20768974 x  ICD9 20/01/2015 23/01/2015 3 R10 500 
178 21668645 x  ICD9 11/01/2015 14/01/2015 3 R10 500 
179 20366100 x  ICD9 26/01/2015 28/01/2015 2 R7 000 
180 20296174  x ICD9 09/01/2015 12/01/2015 3 R10 500 
181 20645289  x ICD9 12/01/2015 15/01/2015 3 R10 500 
182 25498882 x  ICD9 22/01/2015 24/01/2015 2 R7 000 
183 31741341 x  ICD9 03/01/2015 05/01/2015 2 R7 000 
184  23245376 x  ICD9 08/01/2015 11/01/2015 3 R10 500 
185 23373764  x ICD9 16/01/2015 19/01/2015 3 R10 500 
186 23315047 x  ICD9 22/01/2015 25/01/2015 3 R10 500 
187 31788246  x ICD9 13/01/2015 15/01/2015 2 R7 000 
188 31748247 x  ICD9 17/01/2015 19/01/2015 2 R7 000 
189  31759210  x ICD9 06/01/2015 09/01/2015 3 R10 500 
190  23479256 (E. 
Jan) 
x  ICD9 12/01/2015 15/01/2015 3 R10 500 
191 31772676 (Feb 
15) 
x  ICD9 13/02/2015 15/02/2015 2 R7 000 
192 25129651 x  ICD9 06/02/2015 09/02/2015 3 R10 500 
193 31123599 x  ICD9 07/02/2015 09/02/2015 2 R7 000 
194 31773765  x ICD9 19/02/2015 21/02/2015 2 R7 000 
195 31167737 x  ICD9 25/02/2015 28/02/2015 3 R10 500 
196 30344444 x  ICD9 02/02/2015 06/02/2015 4 R14 000 
197 22475172  x ICD9 10/02/2015 13/02/2015 3 R10 500 
198 22884634 x  ICD9 16/02/2015 19/02/2015 3 R10 500 
199 25225574 x  ICD9 04/02/2015 07/02/2015 3 R10 500 
200 20701363 x  ICD9 20/02/2015 23/02/2015 3 R10 500 
201 31782964  x ICD9 11/02/2015 14/02/2015 3 R10 500 
202 22967497 x  ICD9 26/02/2015 28/02/2015 2 R7 000 
203 24863632 x  ICD9 09/02/2015 12/02/2015 3 R10 500 
204 31236623 x  ICD9 12/02/2015 15/02/2015 3 R10 500 
205 25657354  x ICD9 22/02/2015 24/02/2015 2 R7 000 
206 31597438 x  ICD9 03/02/2015 05/02/2015 2 R7 000 
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207 31723026 x  ICD9 08/02/2015 11/02/2015 3 R10 500 
208 20828042 x  ICD9 16/02/2015 19/02/2015 3 R10 500 
209 31735616  x ICD9 22/02/2015 25/02/2015 3 R10 500 
210 31738743 x  ICD9 08/02/2015 11/02/2015 3 R10 500 
211 22471494 x  ICD9 13/02/2015 15/02/2015 2 R7 000 
212 30050827 x  ICD9 06/02/2015 09/02/2015 3 R10 500 
213 21309851 x  ICD9 07/02/2015 09/02/2015 2 R7 000 
214 28059731  x ICD9 19/02/2015 21/02/2015 2 R7 000 
215 24169633 x  ICD9 25/02/2015 28/02/2015 3 R10 500 
216 31748700 x  ICD9 02/02/2015 06/02/2015 4 R14 000 
217 23063274  x ICD9 10/02/2015 13/02/2015 3 R10 500 
218 31746688 x  ICD9 16/02/2015 19/02/2015 3 R10 500 
219 21144928 x  ICD9 04/02/2015 07/02/2015 3 R10 500 
220 31758204 x  ICD9 20/02/2015 23/02/2015 3 R10 500 
221 22988968  x ICD9 11/02/2015 14/02/2015 3 R10 500 
222 24968489 x  ICD9 26/02/2015 28/02/2015 2 R7 000 
223 21458195 x  ICD9 09/02/2015 12/02/2015 3 R10 500 
224 20902573 x  ICD9 12/02/2015 15/02/2015 3 R10 500 
225 30344444  x ICD9 22/02/2015 24/02/2015 2 R7 000 
226 24030470 x  ICD9 03/02/2015 05/02/2015 2 R7 000 
227 21121181 x  ICD9 08/02/2015 11/02/2015 3 R10 500 
228 22580716 x  ICD9 16/02/2015 19/02/2015 3 R10 500 
229 31815590 (E. 
Feb) 
 x ICD9 22/02/2015 25/02/2015 3 R10 500 
230  25697533 x  ICD9 08/03/2015 11/12/2015 3 R10 500 
231  22350946 x  ICD9 13/03/2015 15/12/2015 2 R7 000 
232 31839319 x  ICD9 06/03/2015 09/12/2015 3 R10 500 
233 20449351 x  ICD9 07/03/2015 09/12/2015 2 R7 000 
234 20033684  x ICD9 19/03/2015 21/12/2015 2 R7 000 
235 22760110 x  ICD9 25/03/2015 28/12/2015 3 R10 500 
236 31844681 x  ICD9 02/03/2015 06/12/2015 4 R14 000 
237 21042007  x ICD9 10/03/2015 13/12/2015 3 R10 500 
238 20033684 x  ICD9 16/03/2015 19/12/2015 3 R10 500 
239 23870660 x  ICD9 04/03/2015 07/12/2015 3 R10 500 
240 31248941 x  ICD9 20/03/2015 23/12/2015 3 R10 500 
241 31082589  x ICD9 11/03/2015 14/12/2015 3 R10 500 
242 27241835 x  ICD9 26/03/2015 28/12/2015 2 R7 000 
243 20221691 x  ICD9 09/03/2015 12/12/2015 3 R10 500 
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244 31255599 x  ICD9 12/03/2015 15/12/2015 3 R10 500 
245 20747911  x ICD9 22/03/2015 24/12/2015 2 R7 000 
246 24610339 x  ICD9 03/03/2015 05/01/2015 2 R7 000 
247 24485534 x  ICD9 08/03/2015 11/01/2015 3 R10 500 
248 25604620 x  ICD9 16/01/2015 19/01/2015 3 R10 500 
249 31253941  x ICD9 22/01/2015 25/01/2015 3 R10 500 
250 25636051 x  ICD9 09/01/2015 12/01/2015 3 R10 500 
251 31257108 x  ICD9 12/01/2015 15/01/2015 3 R10 500 
252 21823372 x  ICD9 19/01/2015 21/01/2015 2 R7 000 
253 22010771 x  ICD9 11/01/2015 14/01/2015 3 R10 500 
254 30822480  x ICD9 01/01/2015 05/01/2015 4 R14 000 
255 31257744 x  ICD9 05/01/2015 08/01/2015 3 R10 500 
256 23987662 x  ICD9 16/01/2015 20/01/2015 4 R14 000 
257 31175748   x ICD9 23/01/2015 26/01/2015 3 R10 500 
258 25653858 x  ICD9 19/01/2015 23/01/2015 4 R14 000 
259 31674229 x  ICD9 17/01/2015 20/01/2015 3 R10 500 
260 24919367 x  ICD9 09/01/2015 12/01/2015 3 R10 500 
261 24003915  x ICD9 10/01/2015 13/01/2015 3 R10 500 
262 31556202 x  ICD9 03/01/2015 06/01/2015 3 R10 500 
263 22978456 x  ICD9 08/12/2015 11/12/2015 3 R10 500 
264 21231840 x  ICD9 13/12/2015 15/12/2015 2 R7 000 
265 22772990     x ICD9 06/12/2015 09/12/2015 3 R10 500 
266 30148092 x  ICD9 07/12/2015 09/12/2015 2 R7 000 
267 25461278 x  ICD9 19/12/2015 21/12/2015 2 R7 000 
268 30216725 x  ICD9 25/12/2015 28/12/2015 3 R10 500 
269 31696560  x ICD9 02/12/2015 06/12/2015 4 R14 000 
270 22765333 x  ICD9 10/03/2015 13/03/2015 3 R10 500 
271 31895790 x  ICD9 16/03/2015 19/03/2015 3 R10 500 
272 30025563 x  ICD9 04/03/2015 07/03/2015 3 R10 500 
273 25012303 x  ICD9 20/03/2015 23/03/2015 3 R10 500 
274 26562462  x ICD9 11/03/2015 14/03/2015 3 R10 500 
275  23878390  x  ICD9 26/03/2015 28/03/2015 2 R7 000 
276  21071931 x  ICD9 09/03/2015 12/03/2015 3 R10 500 
277  31206287  x ICD9 12/03/2015 15/03/2015 3 R10 500 
278  31698632 x  ICD9 22/03/2015 24/03/2015 2 R7 000 
279  21899299 x  ICD9 03/03/2015 05/03/2015 2 R7 000 
280 20736112 x  ICD9 08/03/2015 11/03/2015 3 R10 500 
281 31706864  x ICD9 16/03/2015 19/03/2015 3 R10 500 
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282 31714645 x  ICD9 22/03/2015 25/03/2015 3 R10 500 
283 30921993 x  ICD9 08/03/2015 11/03/2015 3 R10 500 
284 20946125 x  ICD9 13/03/2015 15/03/2015 2 R7 000 
285 27364611  x ICD9 06/03/2015 09/03/2015 3 R10 500 
286 21981972 x  ICD9 07/03/2015 09/03/2015 2 R7 000 
287 31670359 x  ICD9 19/03/2015 21/03/2015 2 R7 000 
288 20488490 x  ICD9 25/03/2015 28/03/2015 3 R10 500 
289 21076161  x ICD9 02/03/2015 06/03/2015 4 R14 000 
290 22471494 x  ICD9 10/03/2015 13/12/2015 3 R10 500 
291 22134050 x  ICD9 16/03/2015 19/12/2015 3 R10 500 
292 24876807 x  ICD9 04/11/2014 07/11/2014 3 R10 500 
293 31632144  x ICD9 22/11/2014 24/11/2014 2 R7 000 
294 31620367 x  ICD9 03/11/2014 05/11/2014 2 R7 000 
295 22562227 x  ICD9 08/11/2014 11/11/2014 3 R10 500 
296 31635949 x  ICD9 16/11/2014 19/11/2014 3 R10 500 
297 25883372  x ICD9 22/11/2014 25/11/2014 3 R10 500 
298 31638257 x  ICD9 09/11/2014 12/11/2014 3 R10 500 
299 30772503 x  ICD9 12/11/2014 15/11/2014 3 R10 500 
300 24136681  x ICD9 13/11/2015 15/11/2015 2 R7 000 
 
 
 
